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To My Husband, Yang Wuping and 
My Son, Yang Qian 
Abstract 
The objective of this study was to estimate the age at natural menopause, the 
prevalence of climacteric symptoms and common diseases. It was also to assay the sexual 
function and contraceptive status of perimenopausal Chinese women. A cross-sectional 
survey was carried out among 788 respondents (response rate: 81%) aged 45-55 years. 
Each questionnaire was administrated by the author by face to face interview. The data 
analysis was achieved in SPSS for windows. Surgically and drug-induced menopausal 
individuals were excluded in analysis. 
The mean age at natural menopause was 48.2 years. Women with more parities or 
more babies breastfed tended to have a delayed age at onset of menopause. There was a 
positive linear relation of the duration ofbreast feeding and the age of menopause. Women 
ofhigher socio-economic status had a later age of natural menopause. 
The prevalence of hot flushes, depression, joint problem were 25.9%, 13.7%, and 
29.6%, respectively. The prevalence of vasomotor, psychological symptoms and bone-
joint complaints were 44.5%, 46.2%, 48.4%, respectively. Vasomotor, psychological 
symptoms were associated with the menopause. However, psychological symptom tended 
to decrease after menopause. Bone-joint complaints were correlated to daily activity and 
physical exercise. Perimenopausal women were the most frequent group to report 
climacteric symptoms. The events of categories of symptoms were correlated to each 
other. 
66.4% of all respondents were sexually active. The major reason for no sexual 
•1 
activity was loss of interest. The frequency of sexual activity was correlated to satisfaction 
ii 
on contraceptive methods. The frequencies of enjoyment and orgasms were associated 
i； 
I； with menopausal status and socio-economic factors. There was an interaction between the 
§ . . 
|l sexual function and the disturbance in sexuality. 
ii 
I The prevalence of fracture, heart disease, and arthritis was 0.9%, 10.9%, and 
I 12.4%. The prevalence of heart disease was positively correlated to age. The prevalence of 
1 
j arthritis was correlated with the menopause and the income status. 
1 
j 64.9% of pre- and perimenopausal women had used some form of contraception. 
I The primary forms of contraception were IUD and barrier method. The efficacy and 
I •. 
1 
satisfaction were high. The main benefits of methods were high efficacy, no side-effects 
and ease of use. The number of parities and the frequency of intercourse were related to 
the choice of using IUD and barrier method. However, income was correlated to the 
choice of natural method. 
• 
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Chapter One: Background and Literature Review 
All women who live beyond the age of 55 to 60 years and many of younger ages 
experience a period of transition from the reproductive to the non-productive stage of life. 
The most striking feature of this transition is the cessation of menstruation (1). The World 
Health Organisation indicated that global life expectancy will be 70 years in 2025 (2). If 
the average age of menopause is 50 years, one in every two women will experience about 
30 years of postmenopausal life (3). 
Early age at natural menopause is a potent biologic marker of ageing and health 
(4). There are some environmental factors influencing age at natural menopause. A large 
number of perimenopausal symptoms and some disorders are associated with or possibly 
accelerated by the menopause. Sexuality presents a particular problem for women who are 
approaching the menopause (1). Fertility diminishes but does not stop whereas the 
contraindication for contraceptive methods becomes more during perimenopausal period. 
There are relatively limited data on the age distribution of the menopause and little 
information on the prevalence of perimenopausal symptoms and common diseases, and the 
status of sexuality and contraception in the developing countries. The data particularly 
relating to Chinese women is a little. Thus, we carried out this study among Chinese 
perimenopausal women in Beijing, China. 
Part One: Population at Risk 
l . Inthe World 
There are 470 million women aged 50 years and older living in the world today, in 
other words, older than the average age of natural menopause throughout recorded history. 
The result of this increased survival is that more and more women are living for longer and 
longer periods of time after their menopause (5). The World Health Organisation indicates � 
that global life expectancy will be 63 years in 2000, and almost 70 years in 2025. By the 
year 2025, about 20% of the world population will be older than 60 years (2). 
2. In USA 
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The number of postmenopausal women in the United States is increasing and will 
continue to increase as the population ages and life expectancy increases. In 1991, 43.2 
million of the population were aged 45 years and older (6). A conservative estimate is that 
more than 50 million females are menopausal. Currently, about 3500 women become 
menopausal each day. By 1996, the daily rate will increase to 4000. With life expectancy 
increasing among American women, and a further increase expected from 78.8 years in 
1990 to 81 years in 2005 (2). 
3. In Britain and Other Developed Countries 
Women aged 55 years and over now comprise 15% of the population of Britain 
(3). The percentage of women over age 50 over total population by 1992 in Denmark is 
16.8%, corresponded percentages were 16.1% in Spain, 13.6% in Canada (5). The average 
life expectancy for women in developed countries is around 75 years; approximately 90% 
of women reach the age of 65 years, and 30% reach 80 years (3). 
4. In China 
About half of the population in the Asian countries were to be found in China. The 
demographic giants, China and India, will account for 36 per cent of the world's 
population at the end of the century. Thus, three out of every five Asians will be either 
Chinese or Indian in the year 2000 A.D. (7). The mainland of China had a population of 
1,133.7 million in 1990 (8). Ofthe population, about 20% were aged 45 and above in 1953 
(9). According to the age-sex pyramids of China in 1982 (8), it was conservatively 
estimated that there were about 113.4 million women at ages of 45 and above by 1990. 
5. Summary 
If the average age of menopause is 50 years, most women will spend 
approximately one third of their life time in postmenopausal life; one in every two women 
will experience about 30 years of postmenopausal life (3). Thus the consequences of long-
term oestrogen deprivation in an increasingly ageing female population will be a global 
medical challenge (2). Nevertheless, wherever longevity is such that a sizeable proportion 
of the women survives beyond the menopause, it is important to assess peri- and 
postmenopausal health in that country, in order to improve quality of life and reduce 
unnecessary morbidity in old age (5). 
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Part Two: Review of Physiology of the Menopause (10) 
The menopause is defined as the "permanent cessation of menses." The transition 
from regular ovulatory cycles to the menopausal states is usually not an instantaneous 
event. Rather, it is a series of hormonal and clinical alterations that reflect declining 
ovarian function. To well understand that why some environmental factors influence the 
age at natural menopause, and why some symptoms associated with menopausal 
transition, it is necessary to briefly review the normal menstrual cycle first, then, to discuss 
the events that occur during the transition, finally, to review one characteristic event of the 
physiologic changes during menopause __ menopausal hot flushes. 
1. Review of the Normal Menstrual cycle 
There is a peak endowment of 7 to 8 million primordial follicles at midgestation. 
Follicular atresia starts concurrently, and by birth the number of primordial follicles has 
declined to about 2.5 million. By puberty, it stands at 200,000 to 300,000. 
The normal menstrual cycle is the result of a complex interaction between the 
hypothalamus, pituitary, and ovary. It is further modulated by higher cortical centres, the 
thyroid gland, the adrenals, and peripheral hormonal production. 
The ovulatory cycle starts with the recruitment of many follicles. One of these 
becomes the dominant one and is the source of ovulation. All of the other follicles undergo 
atresia, while many additional follicles find the same fate on a continuous basis. If one 
considers that from puberty to menopause, with a total cohort of 200,000 follicles, only 
about 500 will yield mature oocytes through ovulation, it becomes obvious that atresia is 
the dominant and continuous process in ovarian physiology. This is a key element leading 
to menopause. 
The hormonal levels seen during the normal menstrual cycle have been well 
characterised. It is agreed that estradiol (E2) is the dominant oestrogen. Circulating levels 
of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are characterised by 
a mid-cycle surge. This is a major distinction from all other time in life, including 
menopause, when FSH levels dominate. 
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2. Menopausal Transition 
The transition from regular ovulatory cycles to cessation of menstruation is 
characterised by variation in cycle length and bleeding pattern. 
In the classic study, documentation of hormonal secretion during the transition 
phase revealed extreme variability in sex steroid release that corresponded to menstrual 
cycle. Commensurate with this erratic secretion is the duration and amount of vaginal 
bleeding. The presence of primordial follicles within the transitional ovary assures that the 
likely source of oestrogen is the granulosa cell. 
As follicles fail or are unable to achieve full maturation, corpus luteum formation 
becomes incomplete, inadequate, or absent. Certainly, in co-ordination with the pattem of 
oestrogen secretion, low progesterone may contribute significantly to the abnormal 
bleeding episodes. Recently, the relationship between follicular number and menstrual 
status was studied in women 45 to 55 years of age. The pattern or menstrual bleeding may 
be a better indicator of follicular reserve than age alone. In addition, it was noted that there 
were very few remaining follicles at the onset of menopause. In this context, the 
persistence of functional primordial follicles well beyond the menopause is highly 
unlikely. 
In contrast to oestrogen and progestin, androgen levels remain stable during this 
transitional period. The most sensitive measure of declining ovarian function in the 
perimenopause is that of serum gonadotropins, in particular, FSH. The precise 
mechanisms underlying this rise in FSH are unclear. 
In summary, the years preceding the menopause are characterised by increasing 
I 
I levels of FSH and LH, and overall decreased levels of Ei and P4(Pr0gester0ne) with 
occasional surges in E2. 
3. The Menopausal Hot Flush 
The menopausal hot flush (or flash) has, over the years, been a source of great 
distress for many women and their spouses, and has fascinated many investigators. It is 
estimated that between 60% and 80% of menopausal women experience this event. 
Indeed, this clinical experience has confirmed many important elements about the 
physiology ofhot flushes. 
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The hot flush is a very characteristic event of the menopause, with remarkably 
similar manifestations between individuals. The classic flush is often preceded by a 
prodrome, manifested by a sensation of pressure in the head. This is followed by a wave of 
heat that originates in the head and neck areas and spreads to the upper torso and arms, and 
ultimately involves the whole body. Serial waves may occur. Sweating is the next phase of 
the flush, and again, is more intense in the head, neck, and torso areas. Palpitations are 
sometimes reported. The entire event lasts from a few minutes up to 30 minutes. 
It has now been well established that the hot flush is a physiological event with 
dramatic physical markers. However, the mechanisms underlying the menopausal hot 
flush remain a mystery. 
Part Three: Review of the Definition of Terms 
Since there was confusion in the medical literature regarding the use of terms such 
as menopause, climacteric, premenopause, perimenopause, and postmenopause (1). The 
Scientific Group of World Health Organisation recommended that users of the term should 
define it specifically. Before defining the terms used in this study, the most consistent 
definitions of menopause, premenopause, perimenopause and natural postmenopause, and 
surgical menopause, were reviewed here. 
Menopause refers to the complete or permanent cessation of ovarian function and 
menstruation, and is indicated by the final menstrual period (1, 2, 10). Natural menopause 
is consistently defined as the last menstrual period. It is observed retrospectively as 12 
consecutive months of amenorrhea with uterus and at least one ovary intact and without an 
identifiable cause for amenorrhea (11, 13). Surgical menopause was considered if menses 
were stopped either by a hysterectomy (with or without removal of the ovaries) or by a 
bilateral oophorectomy (11, 13). Premenopause refers the whole of the reproductive 
period prior to the menopause (1). Women were classified as premenopause if they 




conceiving or lactating women or those with other well-defined reasons for amenorrhea 
not related to menopause (11). Perimenopause (or climacteric) is used to include the 
period immediately prior to the menopause and at least the first year after the menopause 
(1). Women who had menstruated within the previous 12 months but not the past 3 
months, or whose menstruation had become irregular, are defined as perimenopausal (11-
13). Women who had not menstruated within the previous 12 months are categorised as 
postmenopausal (1, 13). 
Part Four: Significance ofMenopausal Age 
Early natural menopause is a potent biologic marker of health and ageing and it is 
associated with a substantial excess mortality. The median age at menopause in most 
westem industrialised societies has been consistently shown to be about 51 years. The 
estimated age at menopause was around 48.5 years among the Asian women. However, 
some environmental factors influence the age at natural menopause. 
1. Significance of Age at the Menopause 
Menopause marks the beginning of a stage of life characterised by an increased 
susceptibility to diseases such as coronary heart disease and osteoporosis. It was therefore 
hypothesised that early age at natural menopause would lengthen the duration of the 
postmenopausal stage of life. One study in California investigated the relation between age 
at natural menopause and the duration of postmenopausal life. They found that early 
natural menopause does not lengthen the duration of postmenopausal life(14). 
The relation between age at natural menopause and all-cause mortality was 
investigated in a sample of 5,287 white women, ages 55 to 100 years, naturally 
postmenopausal. After controlled for the confounding factors, women with earlier age at 
natural menopause had a larger age-adjusted odds ratio of death. Ovarian ageing, as 
reflected by age at natural menopause, may be highly correlated to the ageing of other 




biologic marker of health and ageing and it is associated with a substantial excess 
mortality (4). 
2. Determination of Age at Menopause 
The age at menopause in individuals may be obtained by periodically asking them 
about the presence of menstrual cycles (15-17), or it may be determined in retrospect from 
postmenopausal subjects by asking them to recall their age at the time of the final 
menstrual period (18，19). The success of both methods depends on accurate knowledge 
and unbiased reporting of age. The accuracy of the first depends upon the frequency of 
interviews and the completeness of final follow-up. The accuracy of the second depends 
on the quality of recall, which in tum reflects the interval of time since menopause, the 
alertness and motivation of the respondent, and the availability of useful milestone (1). 
3. Distribution of Age at Menopause 
There is paucity of descriptive information about the age distribution of natural 
menopause on populations. In particular, very little is known concerning populations of 
non-European origin. The median age at menopause in most westem industrialised 
societies has been shown to be remarkably constant (3). It is about 51 years varying from 
50.0 to 51.4 years (15-22). There is a little of data from non-westemised populations. 
Some studies have indicated earlier menopause occurred in Asian countries. The estimated 
age at menopause was around 48.5 years ranging from 44.0 to 50.7 years among the Asian 
women (23-30). 
Table Estimated Ages at Menopause in the Asian Countries 
Country and Year of Study Race Mean or Median Study Design 
China 1990 (23) Asian 49.0 mean cross-sectional 
Philippine 1985* (24) Asian 44.0 mean cross-sectional 
Philippine 1994* (25) Asian 48.0 mean cross-sectional 
Thailand 1993* (26) Asian 49.5 mean cross-sectional 
Indonesia 1989 (27) Asian 50.5 mean cross-sectional 
Malaysia 1994 (28) Asian 50.7 mean cross-sectional 
Turkey 1990 (29) Asian 46.2 median cross-sectional 
Japan 1970 (30) Asian 50.2 median cross-sectional 
* Year of the paper published 
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4. Factors Influencing age at Natural Menopause 
The environmental factors influencing the age at natural menopause are the 
follows: reproductive factors, nutrition, and socio-economic status, and smoking. More 
parities and upper socio-economic class have been consistently suggested to be associated 
with later menopause. Cigarette smokers have an earlier natural menopause with a 
substantial relationship to does of smoking than non-smokers. Smokers tend to have not 
only an earlier but also a shorter perimenopause. 
4.1. Reproductive Factors 
There was no association between the age at menarche and the age at menopause 
(15, 26, 31-34). Women with shorter cycle length had an earlier time at the cessation of 
menstruation (15, 35). Some studies reported that women being pregnant or having more 
number of pregnancies had a delayed age at menopause (15, 35, 36). However, another 
study did not agree this (32). The most well documented association was that women who 
I had ever had a live birth or had more parities had a later age at the final menstrual period 
than nulliparous women or those with fewer parties (15, 18, 26, 31, 37-39). 
4.2. Nutrition and Socio-economic Class 
Menarchal and menopausal age may have a common relationship to nutritional 
status (40). Body weight is positively correlated with age at menopause (30, 41). Women 
with malnutrition had approximately 4 years earlier menopause compared with women 
who were not malnourished (3). After adjustment for current cigarette consumption, a 
weak linear relationship between relative weight and age at menopause remained among 
women who smoked (41). However, some studies have found that the age at natural 
menopause was not related to both weight and height (16, 18). 
Socio-economic status, as measured by the level of education, occupation or 
income, was related to age at the cessation of menstruation. Women with high level of 
education had a later age at the onset of menopause (16, 19, 20). Occupation, residence 
and income also have effects on the age at menopause (16, 19, 20, 31). Overall, women of 
high socio-economic status had the menopause later than those of low socio-economic 
status (18, 32). 
4.3. Cigarette Smoking 
I 10 
It was well documented that cigarette smokers have an earlier natural menopause 
than non-smokers (16, 17, 20, 23, 36, 38, 39, 41-44). The age at menopause of smoker was 
about 2 years earlier than that of non-smokers (19). This finding was confirmed by other 
similar studies (16, 17, 20, 42). Smokers tend to have not only an earlier but also a shorter 
perimenopause (17). There was a certain difference of age at menopause between smokers 
and non-smokers, also a substantial overall relationship between the number of cigarettes 
per day and age at natural menopause. For example, the median ages at menopause were 
52.4 for never smokers and 51.9, 51.0, 50.7 and 50.4 years for women currently smoked 1-
14, 15-24，25-34, and 35 or more cigarettes per day (41). 
Part Five: Symptoms Associated with the Menopause 
Many of perimenopausal symptoms have been associated with the menopause due 
to the ovarian dysfunction (45-48). Consistent symptoms include vasomotor symptoms, 
psychological symptoms and bone-joint problems (1, 49). 
1 
1. Vasomotor Symptom 
There is clear agreement that the most characteristic symptoms of the 
perimenopausal period are hot flushes, night sweats, palpitation and headaches attributed 
to vasomotor instability (2, 10, 26, 50-56). The hot flush is a very characteristic event of 
the menopause. It is estimated that between 50% and 85% of menopausal women 
experience this event (2, 10, 56，57), with remarkably similar manifestation between 
individuals. Sweating is the next phase of the flush. Palpitations and headaches are 
sometimes reported. The entire event lasts from a few minutes up to 30 minutes (10, 11). 
2. Psychological Symptom 
Natural menopause led to few changes in psychological characteristics. In the other 
word, natural menopause did not have negative mental health consequences for the 
majority of middle-aged healthy women (58-61). However, psychological symptoms did 
be increased during the perimenopausal period (62-64). The prevalence of psychological 
！ 1 1 
disorders such as depression, fatigue, or irritability differs from the populations (25, 58, 
65-67). 
3. Bone-joint Complaints 
Backaches and joint pain are the common symptoms experienced by menopausal 
women (49). A clear positive trend was demonstrated between menopausal status and the 
prevalence ofjoint pain (62). 
4. Time Relationship of Occurrence to Menopause 
One study has found an increase in psychiatric morbidity occurring before the 
menopause and lasting until about one year after the menopause. Vasomotor symptoms 
increased dramatically when menstrual period stopped and persisted up to five years after 
the menopause. Both these features seemed to have a clear relation to the menopause but 
not the same relation. Thus, psychological symptoms tend to be maximal before and 
vasomotor symptoms after the cessation of menses (68). 
5. Factors Influencing the Occurrences of Symptoms 
The occurrence of perimenopausal symptoms may be affected by cultural, 
menopausal, socio-economic factors. There is an association between the vasomotor, 
psychological, and bone-joint symptoms. 
5.1. Socio-culture 
The attitude of different culture to the cessation of fertility that occurs in the 
middle years of a woman's life varies. In a society, such as the North American, which 
emphasises youthfulness, the menopause is viewed in a negative light. In other more 
traditional societies, a woman may gain status with age and the menopause can even be an 
event for celebration. Such cultural attitudes may well partially determine the range of 
symptoms which women have during the menopause (69-71). Thus, the frequency of 
menopausal symptoms reported by women differences from country to country. Relative 
to women from Canada and the United States, Japanese women were the most likely not to 
report any symptoms: 27% of Japanese women relative to 14% of Canadian and 16% of 
women from the United States reported themselves symptom free. In the other word, only 
20% of Japanese women relative to 34% of Canadian reported that they experienced hot 
flushes (11). A survey on Chinese women in Hong Kong showed that the report rate ofhot 
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flushes was 10% (72), Similarly, only 18% Chinese factory female workers experienced 
hot flushes (73). 
5.2. Menopause Status 
Vasomotor symptom was best predicted solely by menopausal status (51, 53-55). 
A clear positive association was also documented between the menopausal status and the 
prevalence of depression, insomnia andjoint pain (62-64). 
5.3. Interaction and Socio-economic Status 
Depression was positively correlated to the severity of the vasomotor symptoms 
(52, 74). Insomnia is likely to have higher psychological distress and somatic symptoms, 
especially musculoskeletal discomfort and fatigue, coinciding with their insomnia (75). 
Psychological symptoms were strongly associated with socio-economic variable (76). 
Part Six: Disturbance in Sexuality 
Disturbance in sexuality is one of common perimenopausal complaints (10). The 
sexuality of women in mid-life is often ignored, but menopause does not signal the end of 
sexuality (77). A majority of women experience changes in sexual function during 
menopause. Decline in sexual interest was significantly and adversely associated with 
natural menopause rather than age (78-81). The interaction between the complaints was 
also found (82). Positive associations were found between socio-economic status and 
frequency of orgasm, enjoyment of sexual activity (80). Very few of the surveys have 
enquired about sexuality of women in the developing countries. 
1. Prevalence of Sexual Problems 
The prevalence of sexual problems in menopausal women is high and may be 
largely unreported through fear of embarrassment (83). A majority of women experience 
‘ change in sexual function during the years immediately preceding and following the 
menopause�The women may complain of declined sexual interest, decreased sexual 
response, increased painful intercourse, and lessened sexual activity (84-87). One study 
among Australian-bom women aged between 45 to 55 years has found that 31% reported a 
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decrease in sexual interest (78). This figure was the same as that of another survey 
concerning sexual responses of women during the perimenopause (88). 
2. Factors Influencing Sexuality 
2.1. Menopause 
Hormones, both exogenous and endogenous, have play the key roles on peri- and 
postmenopausal sexuality (89, 90). In particular, a subset of women with especially low 
estradiol levels (<35 mg/pl) tends to have reduced sexual activity (88). Decline in sexual 
interest was significantly and adversely associated with natural menopause rather than age 
(78-80). The biological changes accompanying the menopause appears to influence sexual 
interest, behaviour and response ofboth women and their male partners (91). 
3.2. Socio-economic Status and Interaction 
Positive associations were found between higher socio-economic status and 
frequency of orgasm, enjoyment of sexual activity (80). The higher educational level was 
associated with a lowered risk of decreased sexual functioning (78). The interaction 
between the complaints was found by one study. While vaginal dryness affects enjoyment 
and desire for intercourse, only dyspareunia was associated with a reduction in the 
frequency of intercourse (82). 




Disorders resulting from, or possibly accelerated by the menopause include 
postmenopausal osteoporotic fractures, cardiovascular disease, and arthritic disorders. 
Osteoporosis itself is asymptotic. It becomes clinically important when fractures occur. 
There was a significant correlation between early menopausal age and a high rate of 
fractures. Changing from pre- to postmenopausal status is associated with an unfavourable 
effect on lipid metabolism and insulin level that may be relevant to an increased risk of 




1.1. Mechanism of Fractures 
Osteoporosis is possibly accelerated by the menopause. The process of bone 
remodelling involves the resorption of bone by the osteoclasts coupled with bone 
formation by osteoblasts (92). The mechanism of oestrogen-bone interaction is unclear 
(92). The most popular hypothesis is that the effect of oestrogen on bone is mediated by 
calcitonin that acts as direct inhibition of osteoclast activity and therefore reduction in 
bone resorption (93). The second evidence is that oestrogen deficiency increases skeletal 
sensitivity to the actions of parathyroid hormone with a subsequent increase in bone 
resorption (92). The final one is that osteoblasts possess receptors for oestrogen (94). 
1.2. Prevalence of Fractures 
The incidence of postmenopausal osteoporotic fractures in women over the age of 
65 is about 40%. It is reckoned that approximately 0.5% of women over the age of 70 will 
sustain a Colles, fracture each year. Vertebral crush fractures may occur spontaneously 
with normal activity. They cause pain, disability and deformity of the spine. A fractured 
hip usually is a terminal complication. Approximately 27% of women who suffer from 
fracture neck of femur will die within a year of their injury and at least a further 20% will 
be permanently disabled with loss of independence and dignity (92). The prevalence of 
fractures was 7.99% observed from 5134 Chinese women aged 40 to 65 years in Beijing 丨 
(23). Each year in the United Status it causes at least 1.2 million fractures (95). 
) 
1.3. Age and Fractures , 
Using a woman's bone mineral density to predict her lifetime risk of hip fracture 
has been employed (96). The acceleration of bone loss seems to begin around 40 years 
(97). There is linear correlation with age corresponding to an annual decrease of 1 per cent 
and total decrease of 44 per cent among 46 and 86 years of age (98). The incidence rate of 
fracture is marketable higher in women at around the age of 50 (99, 100). 
1.4. Menopause and Fractures 
Before menopause occurs, it is increased with the amenorrheal interval, and the 
probability of amenorrhea increases with age (101). There is an evidence that amenorrhea 
is associated with low bone density (102). Bone loss was accelerated at menopause (103, 
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104). Premature or early menopause had a more severe bone loss and a significantly 
greater frequency ofh ip fracture (105-114). 
1.5. Reproductive History and Fractures 
Women with high parities had a reduced hip fracture risk (115-117). There was a 
dose-response relationship between average duration of breastfeeding per child and risk of 
hip fracture. Breastfeeding may protect parous women against hip fracture in old age 
(118). However, another study has shown that women who breastfed for more than 2 years 
had a risk of fracture similar to women who had never breastfed (119). Women who had 
used oral contraceptives for 6 or more years had significantly higher bone densities of the 
lumber spine and femoral neck than ones who never used oral contraceptives, and the 
increasing duration of use was protective (120,121). 
1.6. Socio-economic Status and Fractures 
The differences in the incidence rates of hip fracture are likely to be related to 
lifestyle (122, 123). Women from the lower socio-economic status were with the lower 
BMD and higher frequency of fracture (124). 
2. Cardiovascular Heart Diseases 
2.1. Menopause and Heart Disease 
There was a strong association between fibrinogen and cardiovascular heart 
diseases (CHD) in women (125). Premenopausal women had significantly lower 丨 
fibrinogen level than postmenopausal women. Menopausal status had independent effects ； 
> 
on fibrinogen level (126, 127). Menopause is associated with enhanced stress-induced / 
cardiovascular responses and elevated ambulatory blood pressure during the workday 
(128), and adversely affects the lipid and lipoprotein metabolism (129, 130). These effects 
may contribute to the risk of cardiovascular morbidity and mortality after the menopause. 
It was shown that early cessation of ovulatory function increases the risk of 
myocardial infarction, and other coronary heart disease (131-133). The incidence rates of 
coronary heart disease in perimenopausal and postmenopausal intervals were twice as 
those in premenopausal intervals (133). However, some investigators concluded that an 
early menopause could not be considered as a risk factor for coronary heart disease (134, 
135). 
2.2. Oral Contraceptive Use and Heart Disease 
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Women with a history of oral contraceptive use had significantly lower fibrinogen 
level that is a risk factor of heart disease than women who had never used. These 
differences persisted after age standardisation (126, 127, 136). However, a use of oral 
contraceptives appears to induce an increase of insulin-resistance markers, which have 
recently been cited as risk factors for ischemic vascular disease (137, 138). It also has been 
shown that O.C. use is associated with a consistent increased in lipoprotein level (139). 
Unfortunately, another study found that O.C. use increased myocardial infraction (MI) 
risk 1.8-fold overall and 2.8-fold among non-smokers without other risk factors (140). 
3. Arthritic Disorders 
3.1. Menopause and Arthritis 
The relation of the onset of symptoms of rheumatoid arthritis (RA) with the last 
menstrual period for women has been studied (141). The average women develop the first 
symptoms at the time of her menopause. Among 23 gouty arthritis in women, 21 (91%) 
developed gout after menopause onset (142). 
3.2. Reproductive Factors and Arthritis 
Early menarche increased the risk of rheumatoid arthritis, when compared with 
women who experienced menarche at age of 13 years, the age-adjusted relative risk of 
rheumatoid arthritis among women with early menarche was 1.9. There were, however no 
f' 
significant associations between parity, age at birth of the first child, and the incidence of , 
I 
rheumatoid arthritis (143, 144). 
The association between oral contraceptive use and the risk of rheumatoid arthritis � 
(RA), have not consistently shown yet. That is, a negative association was found between 
the onset of rheumatoid arthritis and the previous use of contraceptive and non-
contraceptive hormones (145-147). The incidence rate of rheumatoid arthritis among oral 
contraceptive users was halved (148). The preventive effect of oral contraceptive use on 
the risk of RA was found to be independent ofthe dose, duration of use (149). In contract, 
none of a protective effect of past or current use of oral contraceptives was shown for RA 
(150-153). The lack of a protective effect was independent of age, disease severity and 
disease end point (154). 
3.3. Socio-economic Status and Arthritis 
1 7 
The strong associations were found between educational level, occupation and 
income and prevalence and severity of arthritis (155). It was found that a trend towards an 
association between lower levels of education and more severe disease at onset. It was also 
found that patients with lower levels of education showed a trend towards a worse 
outcome (156). Subjects who had more than a high school education were found to have 
received more comprehensive care than any other subgroup (157). Patients with RA with 
higher levels of formal education were more likely to be hospitalised or to undergo surgery 
for RA (158). In one study, at least 28% of patients had lower annual income compared to 
the year before disease onset (159). Disease characteristics were followed in importance 
by socio-economic factors (160). 
3.4. Smoking, Drinking and Arthritis 
Cigarette smoking had a slight increase in the risk of rheumatoid arthritis (143, 
161). A negative association between smoking and largejoint osteoarthritis was found by 
one study (162). However, alcoholic drinkers had a reduced risk of rheumatoid arthritis 
(161). 
Part Eight: Contraception for Perimenopausal Women 
Fertility-regulation is one of the particular problems facing the perimenopausal ！ 
woman. Despite a substantial reduction in natural fertility at this time, pregnancy can | 
I 
occur. For contraceptive woman, contraindication for contraceptive methods becomes , 
more among middle-aged women. It may be difficult to determine which method is the 
I most appropriate. The Scientific Group has recommended that studies should be 
performed on women in the age group 45-54 years to monitor the safety, efficacy, 
complication rates, and acceptability of contraceptive methods. 
1. Decline in Fertility 
For those women who have not sterilised, mid-life is a period of waning fertility 
(163). The fertility declined towards to the decades. Two hundred years ago, in parts of 
Europe where there was no voluntary control of fertility, 30% of all births occurred in 
women over 35 years of age. Even a decade ago one in 10 births occurred in women of 
this age group, but today it is less than one in 20. Even in traditional societies the mean 
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age for having the last child is 40, although the menopause may not come for another 10 
year (69). A consistent feature of all societies is the marked decrease in fertility 7-10 years 
before the menopause. According to the US Bureau of Census statistics for 1976, live birth 
rates per 1,000 mothers showed a tremendous decline from the period ofhighest fecundity: 
121.1 for ages of 20-24, in comparison to 4.3 for ages of 40-44 (164). The evidence of this 
stage of fertility is that modem endocrine assays have shown a change in follicle 
stimulating hormone (FSH) and oestradiol levels at age of 40, 10 years before the 
menopause (165). 
2. Decline in Sexual Activity 
Apart from a woman's biological clock, another important factor is a decline in 
sexual activity with advancing year, especially after 40. The frequency of sexual activity at 丨 
40 years is about half that at 20 years and will decline further thereafter (166). In both men 
and women sexual behaviour in middle age is greatly influenced by socio-cultural 
background. In some parts of Asia there is evidence that frequency in couples aged 
between 40 to 50 is very significantly lower than among those in the West. Two-thirds of 
women are abstaining sexually by the age of 40 and nine-tenths by the age of 46 (69). 
3. Risk ofBeing Pregnant | 
Fertility diminishes gradually over a number of years but it does not stop. The 丨 
occurrence of ovulatory menstrual cycles is unperiodicable. The evidence suggests that as 
1 
long as women are having regular menstrual cycles they are still potentially fertile. Of 
f 
those women who reported no change in menstrual frequency, 95% ovulated in every � 
cycle (167). Moreover, irregularity does not mean sterility; A woman of 45 who has gone 
six months without a period still has a 50% chance of ovulating once more (69). No 
women should consider herself free from the risk of pregnancy until at least one year after 
her final menstrual period (168). 
4. Risk ofUnplanned Pregnancy 
Neither is pregnancy in women aged 40 and above planned and nor is pregnancy 
without risks. The most important risk of an unwanted pregnancy is induced abortion. 
Among women over the age of 40 there is a legal abortion rate of up to 45% of the 
conception rate. This rate is significantly higher than for any other age group (168). 
Another study found that abortion was reported by 28% of the women aged 40-60 years 
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(169). However, the frequency of illegal abortion will never be certain. Being illegal, its 
occurrence will be known only to the pregnant woman and whoever performs the abortion, 
both deeply interested in keeping it secret (170). The spontaneous abortion rate between 
the ages of 40 and 49 years reaches 26% (171). For those women who, or whose husband 
has not sterilised, the choice of method can be complex because of the need to strike a 
balance between the acceptability, efficacy of the method and the potential risk to health. 
5. Implications in the Use of Contraceptive Methods. 
Hormonal contraceptives, intrauterine devices, barrier methods, sterilisation and 
periodic abstinence could be the considerations with regard to individual methods of 
family planning in perimenopausal women. The most effective methods of contraception 
are hormonal contraceptives and intrauterine devices (IUD) (172). However, 
contraindication for contraceptive methods becomes more among middle-aged women. It 
may be difficult to decide which contraceptive method is the most appropriate. 
t 
5.1. Oral Contraceptive 丨 
j 
At present about 60 million women are using oral contraceptives (173). The 
triphasic oral contraceptive is the treatment of choice in prevention and treatment of 
menopausal symptoms during the perimenopause (174). There was a very high prevalence 
of oral contraceptive among young women (175-177). However, less frequent use of oral ^ 
contraceptives was found in the middle aged women (169, 178). ’ 
II 
The efficacy and acceptability of orally administered steroid contraceptives are ‘ 
i 
well established. Oral contraceptive use truly provides reliable contraception with good , 
general tolerance and excellent cycle control and very low rate of side effects (179-184). 
The particular problem of its use among middle-aged women is that oral 
contraceptive use interferes with natural cyclical bleeding and therefore makes the woman 
be unable to know when she has reached her menopause (1). 
5.2. Intrauterine Devices 
A comparison of IUD users by age at IUD insertion and age at IUD removal or last 
visit to the clinic showed that women over 40 tolerated IUDs better than younger women. 
Besides a lower number of pregnancies, there was also a decrease in the number of 
expulsion and IUD removals for pelvic infection diseases in this age group (185). Thus, 
the frequency ofIUD use increased with age (178). 
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The annual pregnancy rates for IUDs ranged from 0.0 to 1.7 per 100 women (186-
188). Some devices have shown no increase in the risk of pregnancy even after 10 years 
(189). The use of the IUD in perimenopausal women has the advantage that it does not 
interfere with natural cyclical bleeding and therefore enables the women to know when she 
has reached her menopause (1). 
A major problem of IUDs has been the increased incidence of bleeding or 
dysmenorrhea. For those women, progestin-releasing IUDs are recommended because of 
their ability to reduce the amount of menstrual blood loss. This new approach may be a 
well-tolerated treatment alternative in perimenopausal women (190). The uterine bleeding 
or spotting, which sometimes occurs with the use of IUDs, may create special problems in 
the perimenopausal period since it may mask pelvic pathology, particularly uterine 
malignancy (191). 
5.3 • Barrier Methods | 
In the light of reduced fertility in the perimenopausal age group the use of 
diaphragms with contraceptive creams or condom may provide a sufficient level of 
protection against pregnancy. However, the age-specific data on these methods, as used by 
perimenopausal women, are fewer. One study in a sample of 1746 women aged 40-57 
years reported that barrier predominated among contraceptive methods (169). Of subgroup 
women at ages of 40-44 years, about one- tenth of them had used condoms (178). 
Condom usage was associated with reduced sexual excitement (192), and it I 
becomes worse for the perimenopausal women with atrophic vaginitis. I 
5.4. Sterilisation � 
Both male and female sterilisation are increasingly popular. 27% of married 
women are sterilised and estimated 30 million men have undergone voluntary sterilisation 
in China (193, 194). The sterilisation rate increased by age and in the 40-44 age group one 
out of every three women (36.4%) was sterilised (178). The efficacy of sterilisation may 
I differ from the type of tubal sterilisation. The annual pregnancy rate differs from 0.0 to 4.3 
per 100 women (195-198). There are no long-term systematic side effects either on 
‘ ovulation or on menstrual blood loss (199-202). 
Sterilisation for women at this stage of diminished fertility is not so necessary. The 
mortality associated with the procedure in a developed country is estimated to increase 
with age (1). Careful counselling is need before this procedure is undertaken (203). 
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5.5. Periodic Abstinence 
Periodic abstinence is less effective than other available contraceptive methods. 
There are no currently available reliable data to assess the feasibility or efficacy of 
periodic abstinence in this age group. That is, it is not known whether the symptoms of the 
fertile period can be identified as readily by perimenopausal women as by those in 
younger age group (204). Because of the irregularity of ovulation and menstruation in the 
time of perimenopause, periodic abstinence is inappropriate as a contraceptive method. 
Part Nine: Significance and Objectives of This Study 
1. Lack of Comprehensive Data Relating to Chinese Women 
A few studies on the menopause were carried out among Chinese women (23, 72, 
1 
'I 
73). Chinese factory workers of Fujian origin were studied (73). Chinese women in Hong |i 
[j 
Kong recruited from four sources were also observed (72). Both studies observed the self-
selected population, and focused only on the prevalence of climacteric symptoms. A study | 
• { 
carried out in Beijing investigated the age at natural menopause and influencing factors, 
ii 
the prevalence of menopausal symptoms and fractures (23). Our study is more 
[ 
comprehensive one. The age at natural menopause, the prevalence of perimenopausal 1 
f 
symptoms and common diseases was estimated, and the sexuality and contraceptive status |, 
were also assayed in a population-based sample. / 
2. The Objectives ofThis Study 
A. To estimate the age at natural menopause among Chinese women 
B. To examine the prevalence of climacteric symptoms of Chinese women 
C. To assess the general health conditions ofmiddle-aged Chinese women 
D. To investigate the sexuality in Chinese women at mid-life 
E. To obtain the contraceptive status of perimenopausal women 
F. To explore the potential influencing factors on the age at natural menopause, the 
prevalence of climacteric symptoms and common diseases, sexuality and contraception 
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Chapter Two: Methodology 
The data for this study was collected in a cross-sectional survey performed in 1995. 
Women who aged from 45 to 55 years were randomly sampled from two urban districts of 
Beijing City in China. Seven hundred and eighty-eight respondents were observed 
(response rate: 81%). Each questionnaire was administrated by the author by face to face 
interview. The data analysis was achieved in SPSS for windows. Surgically menopausal 
and drug-induced menopausal women were excluded in the analysis. The total of 742 
women who were pre-, peri- or naturally postmenopausal was analysed. 
i 
Part One: Method of Data Collection 
I 
1. Sample Size Estimation I 
2 
The sample size was estimated by the formula (205): n = ^ ^ ^ . where q = l - p . P 
d 
is the proportion in the population possessing the characteristic of interest. Our estimate 
was based on the prevalence of hot flushes among Chinese women in Hong Kong. It was 
10% (72). D is the maximum difference between the proportions of study population and 
the reference population that you can tolerate. It was allowed as 2%. When a = 0.10, z = 
I 
1.645. Thus, the sample size of study was 610. '| 
2. Study population and sampling ! 
2.1. Study Population and Organisation in Beijing , 
Study population was the urban female residents aged from 45 to 55 years in 
Beijing, China. Sampling was carried out in the urban area of Beijing City. The structure 
tree of the Government Organisations in the cities in China is as follows: 
City Government Organisation 
丄 
District Government Organisation 
山 
Subdistrict Office ^ 
Neighbourhood Committee 
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This chart showed the sample frame. Filled squares or cycles mean the sampled units. 
^ ^ H City Government Organisation 
^ H District Government Organisation 
H Subdistrict Office w^ w 
_ Ten Neibourhood Committees in Xi Cheng District (not on sequence) 
# Fifteen Neibourhood Committees in Xuan Wu District (not on sequence) 
；! 
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2.2. Sampling Study Districts ！ 
The method of sampling was cluster-stratified. There are four urban districts in f 
|) 
Beijing City. According to the fixed sequence, they are Dong Cheng, Xi Cheng, Chong 丨  
I 
Wen and Xuan Wu District. Xi Cheng and Xuan Wu Districts were randomly drawn as the \ 
sampled districts. 
2.3. Sampling Study Subdistricts 
The officers in Beijing Family Planning Committee (City Government 
Organisation) and District Family Planning Committees in two sampled districts (District 
Government Organisations) were requested to provide the lists of all subdistrict offices, 
which were in fixed order as usual. There are eight subdistrict offices in Xuan Wu District 
and ten in Xi Cheng District. One subdistrict was withdrawn at random from each sampled 
district to be the sampled subdistricts. It was drawn randomly that Chun Shu Subdistrict 
Office was from Xuan Wu District and Zan Lan Lu Subdistrict Office was from Xi Cheng 
District. 
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2.4. Sampling Study Neibourhood Committees 
Chun Shu Subdistrict There are 35 neighbourhood committees in Chun Shu 
Subdistrict Office of Xuan Wu District. The officer in Subdistrict Office provided the 
estimated number of women at target age. At first, all of 35 neighbourhood committees 
were sorted on the number of target women. Then the sorted committee list was equally 
divided into 5 sections. Each section contains 7 committees. Third, one committee was 
drawn randomly according to sequence number from each section. 
The officers of the first 5 neighbourhood committees were required to provide the 
actual number of target women and the correspondent name lists of women aged from 45 
to 55 years within the inclusion criteria. The required items on the name list were full 
• • 1 
name, date of birth, and address. Those women who are not living in the sampled district, 丨丨 
f 
I 
only registrated here and were not staying in Beijing City during the period of interview , 
were not included in the name list. | 
After collecting the name list, the number of women was summarised within those 丨 
5 neighbourhood committees. It was about 150. On average, it was 30 from each 
committee. On calculated, a total of 350 respondents was planned to be interviewed from i 
. t 
each subdistrict. The response rate of 75 percent was expected. About 470 women would 
be contacted in each subdistrict. Thus, 15 neibourhood committees should be drawn in ^ 
Chun Shu Subdistrict. Three committees were drawn at random using the sequence > 
: ！； 
number of neibourhood committees section by section. ;) 
Zan Lan Lu Subdistrict There are 50 neighbourhood committees in Zan Lan Lu | 
Subdistrict of Xi Cheng District. The committee list was divided into 10 sections equally. ( 
Each group consists of 5 committees. The population density is higher than that in Xuan 
Wu District. One Neibourhood Committee was drawn randomly from each section. 
Finally, 10 Committees were grouped as the final study sample from Zan Lan Lu 
Subdistrict. 
2.5. Inclusion Criteria 
• Chinese women 
• Living in the urban area of Beijing City 
• Ages ofbetween 45 to 55 years 
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2.6. Exclusion Criteria 
• Being deaf - mute 
• Seriously ill or hospitalised 
• Mental disease or disorder 
2.7. Difference between Two Districts 
Most people in Xuan Wu District have lived in single-story houses. In this 
condition, several families share a little corridor with one gate and one water tap. Since 
there are more houses in poor conditions (noisy and moistures, short and small) in Xuan 
Wu District, more people have moved to other district when they become married or get 
apartments from their working units or companies, but the registrations of ID have not 
changed yet. While the government or companies pull the old houses down to set up some j 
I 
buildings, they will have rights to own new apartments instead of the old house. | 
On the other hand, most people in Xi Cheng District have lived in apartments. The 
li 
population density is much higher than that in Xuan Wu District. ；丨 
,i 
2.8. Co-operation with the Members in Committees 
The members of all sampled neighbourhood committees were called to come : 
i!. 
together for a conference. The requirements of the respondents and the arrangement of 
interview were presented at the meeting. It was also settled the responsibility of ； 
iy 
. (i. 
interviewer and members, and the way to contact with the subjects. After that, the ) 
committee member was contacted one by one. ', 
f 
2.9. Response Rate ( 
A potential subject was contacted or scheduled for two times for interview in the 
different section: one was in the office hours and another was out of the office hours. If 
she still had not participated, she was considered as non-responded. 
The total number of women at ages of 45 to 55 years from all sampled 
neighbourhood committees was 970. Ten met the exclusion criteria. One hundred and 
eighty-four women were not responded. Finally, seven hundred and eighty-eight women 
responded. The response rate was 81%. Only the ages of the non-responded women were 
available. No difference in ages was found between the responded and the non-responded 
women. The mean age of the non-responded women was 49.20 years (n=184, SD=3.33), 
whereas the mean age of responded women was 49.19 years (n=788, SD=3.34). 
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3. Data Collection 
3.1. Content of the Questionnaire 
All data was recorded on the standardised questionnaire (Appendix). It was based 
on one developed by Department of Community and Family Medicine (The Chinese 
University of Hong Kong) that was modified from one used in the Massachusetts 
Women's Health Study. The questionnaire covered the following characteristics: 
1. Menstruation in the past 12 months 
Menopausal status was defined retrospectively according to the menstruation in the 
past 12 months (13). The year and the month of the final menstrual period were recorded 
for those naturally postmenopausal women. 
• Premenopause: women who had menstruated regularly. | 
:i 
• Perimenopause: women who had menstruated within the previous 12 months but | 
r 
not the past 3 months, or whose menstruation had become irregular. [ 
• Natural postmenopause: women who had not menstruated within the previous 12 |' 
i 
(,i 
months without an identifiable cause. 
• Surgical menopause: women who had either hysterectomies or bilateral :: 
i 
oophorectomy. (Women with hysterectomies may still have functioning ovaries, but | 
i:. 
there is no way to determine their menopausal status without a hormone assay.) 1 
i/ 
• Drug-induced menopause: women whose menstruation had been stopped by taking 丨 
I 
some hormonal drugs. 
jf 
2. Climacteric symptoms: vasomotor symptoms, psychological symptoms, and bone-joint �: 
complaints were embedded in long lists of 22 common symptoms. Women were asked 
to check which symptoms in these lists they had experienced within the previous two 
weeks; 
3. Sexuality: Frequency of sexual activity, sexual function, and disturbance in sex; 
4. Common diseases, such as fractures, heart disease, and arthritis; 
5. Contraception: in particular, pre- and perimenopausal women who were sexually 
active and current users were asked the questions related to the items in contraception 
section. 
6. Menstrual and reproductive history, for example, age at menarche, number of parities, 
and oral contraceptive use; 
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7. Medication: use ofhormonal drugs and other drugs; 
8. Marital and socio-economic status; 
The following taxonomy of occupational classes was utilised (19). 
A. Upper white-collar workers: Upper-level employees with administrative, 
managerial, professional, or related occupations. 
B. Lower white-collar workers: Lower-level employees with administrative and 
clerical occupation, such as research assistants, technicians, clerical workers and 
nurses. 
C. Blue-collar service workers: Blue-collar workers employed in distribution and 
service work, that is, those who are not in factories or production. 
D. Blue-collar factory workers: Blue-collar workers employed in industry or other \ 
\ 
production work, such as industry, electricity, gas and water works. ( 
I 
9. Habits, including smoking, drinking, physical activity. 丨 
3.2. Pre-test of Questionnaire 丨 
'I 
The purpose of pre-test was to test the ability of questions being understood and 丨 
the expression of the questions. The first version of questionnaire was tested among 10 ,„ 
middle-aged women at ages of 43 to 56 years. The responded women were the staff of the 丨 
f' 
National Research Institute for Family Planning and the residents of the 12 Da Hui Si [: f 
I Neibourhood Committee. After reviewing the tested questionnaires, the questionnaire was 1 
； I 
modified and completed for the first time. f 
； 3.3. Pilot Study | 
! y 
Objectives ‘ 
i • To examine whether the way of contacting with the committee members and of 
booking the appointment with the clients is sufficient and convenient or not; 
• To determine the average time of one interview taking; 
• To account the rate of employed women at this age group for scheduling the 
timetable for interview; 
• To assay the age range of study population is suitable or not (e.q. What is the 
proportion of naturally postmenopausal women); 
• To test the ability of questions being understood and the expression of the 
questions among the actual study population. 
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Results 
The pilot study was carried out in one sampled neibourhood committee. It was 
better to contract with women by the guiding and introducing of the members in the 
Neibourhood Committees. Each interview took about 30 minutes including greeting with 
subjects and answering some questions in which women were interested. The total number 
of studied women were 28. About half of them were employed. 28.6% of women were 
classified as premenopausal; 32.1% of women were defined as perimenopausal; and 35.7% 
were categorised as naturally postmenopausal while 3.6% were grouped as surgical 
menopause. The age at natural menopause was 49.0 years with the range of 42-54 years. 
The frequency of climacteric symptoms was 59.3% whereas the perimenopausal group 
was the highest one of 77.8% among three menopausal groups. 丨 
3.4. Interview ^ 
. . . I 
Before interview, an appointment was booked with the clients according to the 丨 
i 
I 
name lists. A second time was available for those women broke the first appointment due “ 
ii I 
r ] i i 
to some personal or other reasons. 丨 
Interview method was face-to-face interview. The interview was performed either 
, ！ i 
at clients' house or at neighbourhood committee office, which was up to the clients. Each | 
questionnaire was administrated by the author. 丨 
The timetable was scheduled into two parts. The office hour was scheduled mainly ^ 
for those women who were not employed yet. It was from 8:00 AM--11:30 AM and 2:00 }• 
PM--5:00 PM. Out-of office time was scheduled for those women who were employed. It | 
was from 7:30 AM--8:00 AM and 6:00 PM- 10:00 PM from Monday to Friday and from •丨 
9:00 AM to 10:00 PM on Saturday and Sunday. 
The interviewing was conducted over a period of three and half months. Both 
instructions and coding guideline were available for questionnaire. 
4. Quality Control 
i 
The sub-sample of 5% of respondents was reinterviewed for quality control with an 
interval of one to two months after first interview. A sub-sample of 39 women was 
reinterviewed. The average number of errors was 16 with the range of 5 to 26 errors within 
114 variables. The average error percentage was 14.1% between the first and the second 
interview among 114 variables. 
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The error distribution between the first and the second interview for five key 
variables were shown as follows: 
Twenty-one naturally postmenopausal women were reinterviewed. The average 
difference of date at the final menstrual period was 10.8 months (SD = 15.2) with the 
range of 0 to 48 months (Table 1). 
Table 1. The Difference ofDate at the Final Menstrual Period in Month 
Difference | Number of subjects 
•…0 1•••"7 
……1 i…“"5 
l 2 j••…3 
"13-24 1•.…'3 
"36-48 1••…'3 ^ 
T^a l i""2T I 
!i 
I 
The errors of perimenopausal symptoms were 15.4%. The errors of occurrence of [ 
j'i 
listed disorders were 20.5%. The errors of sexually active women were 15.4%. The errors 1 
of contraceptive women were 5.1% (Table 2-5). ;j 
！ 
I 
Table 2. The Difference of Occurrence of Table 3. The Difference of Occurrence of 
Perimenopausal Symptoms Listed Disorders [ 
I 
1st Interview 1 st Interview 
i 
2nd Interview Yes No 2nd Interview Yes No 1^  
Yes 29 2 Yes 14 0 | 
No 4 4 No 8 17 \) 
Table 4. The Difference of Sexually Table 5. The Difference of Current 
Active Women Contraception Women 
1 st Interview 1 st Interview 
2nd Interview Yes No 2nd Interview Yes No 
Yes 19 4 Yes 8 2 
No 2 14 No 0 29 
5. Data management 
3 0 
f 
After interview, each questionnaire was checked before data coding and entry. If 
there were some omitted places, they were made up by phone calls or letters. Data coding 
was done by author according to the coding guideline. 
Data entry was performed using dBase 4 software. The first data entry was done by 
the author. The second one was done by a trained assistant. While the data was entered 
twice, the double checking was achieved to make sure that two sets of data files were 
exactly the same. If somewhere was not equal, it was corrected according to the original 
questionnaire. Exploring data by SPSS for windows confirmed the consistence in logic of 
the data. 
Since the information was private, all records collected was kept confidential. The 
first of all, the name lists, questionnaires, diskettes were locked in a specified cabinet. The :( 
I 







Part Two: Method ofData Analysis 丨 
n 
s ！ 
1. Type ofVariables Used in the Analysis (206) 
I 
Two basic types of variables were used in the analysis: categorical and ; 
continuous. Categorical variables were those having values that could fall into only a , 
.I| 
limited number of separate categories with no possible intermediate levels. If values of a | 
! l , 
categorical variable could be categorised as one of only two alternatives, it was defined as f 
dichotomous variable, such as the occurrence of hot flushes was either yes or no. When ‘ 
more than two alternative categories were possible, the variables were termed 
multichotomous. For example, the regularities of menstruation were regular, irregular, no 
change, or stopped. 
In contrast, continuous variables were those that theoretically can assume all 
possible values along a continuum within a specified range. Such variables were not 
^ 
restricted to particular values and, in fact, were limited only by the accuracy and precision 
of the measuring instrument, for example, age at menopause, body weight and height. 
When continuous variables were treated as categorical variables, the cutting point 
was either 50 percentile or 25, 50, and 75 percentiles. 
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. 2 . Grouping of Climacteric Symptoms 
Vasomotor symptom Hot flushes, night sweats, palpitations and headaches were 
grouped as vasomotor symptom (3). 
I . 
Psychological disorders Depression, insomnia, nervousness, tiredness and inability 
in concentration were considered as psychological disorders (2,3). 
Bone-joint problems Backaches and joint problems were categorised into bone-
joint problems (49). 
3. Computing Ages and Body Mass Index 
3 • 1. Age at Natural Menopause and First Birth 
The age at natural menopause was computed from the date of the final menstrual / 
period of naturally postmenopausal women minus the woman's date of birth. The year and f 
the month of the date were requested in the questionnaire. The equation is as follows in I 
'.; 








In the same way, the age at first birth was calculated from the woman's and the 
f, 
first child's birth date. 
3.2. Body Mass Index j 
Body mass index (BMI) was computed from self-reported height in meter and v 
' ' 
weight in kilogram as follow (15): \/ 
BMI = Weight/height^ Equation 2 
4. Statistic Methods 
Data analyses were executed among pre-, peri-, and naturally postmenopausal 
women. Surgically menopausal and drug-induced menopausal women were excluded in 
the analyses in this study. Both descriptive and analytic analyses were performed. 
Descriptive analysis: For categorical variables, such as the prevalence of symptoms, 
common diseases, disturbance in sexuality and contraceptive status was described by 
menopausal status. For continuous variables, such as age at natural menopause, mean, SD 
3 2 
|i 
and the range were executed. All equations used in statistics were quoted from SPSS for 
windows (207). 
4.1. Chi-square Test 
To measure the association between two categorical variables, for example, the 
occurrence of symptoms and the menopausal status, Chi-square test was archived. 
4.2. t-test 
The question is not whether the two sample means are equal, but whether the two 
population means are equal. If independent variable is dichotomous, for example, smoking 
or not, t-test was performed. 
If variances are not equal, t value was calculated: 
/ 
I 
^ — J[~ i 
t = 1 2— Equation 3 
^uK y 




Where X^ and X: are the sample means. S^ and S\ are the variances. N^ and N) are � 
the sample sizes of two groups. 丨 
If the two variances are equal, the individual group variances are replaced by a 丨！ 
2 i|.:.' 
pooled estimate Sp . 丨‘: tf p 
0 
-^^ -^^ :r: 
t = 1 2— Equation 4 丨, 
K ^ 
仏 ^ 2 
where Sp ,^ the pooled variance, is a weighted average of the individual variances and is 
calculated as 
= W - l ) � + ( " 2 - l ) & 2 Equation 5 
P N,+N^-2 
4.3. One-way ANOVA 
3 3 
To test the null hypothesis that several population means are equal, if independent 
variable was multichotomous, categories of job, for example, One-way ANOVA was 
executed. 
4.4. Simple Linear Regression Model 
If both dependent and independent variables were continuous variables, such as 
age at natural menopause and age at menarche, simple linear regression model was used. 
The model can be summarised by 
Yj = Po + PiXi Equation 6 
The significance level of Pi less than 0.05 means Pi differs zero. The regression ( 
coefficient can be interpreted as the change in the linear relation with a one-unit change in ) 
the independent variable. 丨; 
4.5. Logistic Regression Model 丨丨 
• I j 
If dependent variable was dichotomous variable, for example, the symptoms |丨 
occurred or not, independent variable was either continuous or categorical, such as years !: 
of education or menopausal status, logistic regression model was employed. To determine , 
whether the association was adjusted by other variables, multiple logistic regression J 
\ ‘ 
analysis was executed finally. f; 
^ 
In logistic regression, we directly estimated the probability of an event occurring. | 
i(; 
For the case of a single independent variable, the logistic regression model can be written |^ ' 
：/ 
as: ‘ 
g P o + P l ^ 
Prob (event) 二 p(>+p ^ Equation 7 
1 ~F" ^ 
where Po and p^  are coefficients estimated from the data, X is the independent 
variable, and e is the base of the natural logarithms, approximately 2.718. 
For more than one independent variable, the model can be written as: 
e' 
Prob (event) = Equation 8 
where Z is the linear combination 
3 4 
Z = P 0 + P 1 X 1 + P 2 X 2 + . . . . . . + PpXp Equat ion 9 
The probability of the event not occurring is estimated as: 
Prob (not event) = 1-Prob (event) Equation 10 
The probability estimate always is between 0 and 1, regardless of the value of Z. 
The odds of an event occurring are defined as the ratio of the probability that it will 
occur to the probability that it will not. 
/ 
i 




Since it is easier to think of odds rather than log odds, the logistic equation can be 丨 
written in terms of odds as: 
'|r 
ir' 
Odds - P r # ^ 0 二 A+PiXi+...+p,A = A e P i Z i � e P A Equation 12 j 
Prob(not) f 
|i.. 
Odds Ratio = Exp (p) Equation 13 | ' 
丨.(、,丨 
. . {| 
An OR value greater than 1.0 indicates a positive association, or an increased risk '/ 
t 
among those within a factor; Analogously, an OR less than 1.0 means that there is an 
inverse association or a decreased risk among those exposed to a factor. 
If the independent variable is continuous, OR can be interpreted as the change of 
possibility of the event happening with a one-unit change in the independent variable. If 
the independent variable is categorical, OR can be interpreted as the likelihood of 
possibility of the event happening than reference group in the independent variable. 
95% confidence level (C.I.) of odds is calculated by the following equation (205): 
95% C.I. = Exp (P±1.96SE) Equation 14 
3 5 
Chapter Three: Results 
Part One: Sociodemographic Characteristic 
92.3% of seven hundred and forty-two women were married and lived with their 
husbands. 5.1% of them were divorced or separated. The percentages of widows and 
single women were 1.8% and 0.8% respectively (Table 1-1). 
Table 1-1. Marital Status of742 Women 
Marital Status I No. of women ; Percentage 
M a S S p685 j '9Z3 
Divorced, Separated i ；^& 5.1 
"Widom I•.…13 1……l"'8 
Sin^es |••••..6 ！•…0.8 
About 11% of women were educated at the level of primary school. More than 
one-third (37.3%) of women graduated from the middle schools. About one-third (30.3%) 
of them had a high school diploma. Almost twenty percent (19.9%) had an educational 
level at or above the level of college (Table 1-2). 
Table 1-2. Education Levels of742 Women 
Degree i No. of women 1 Percentage 
N(me j••…11 f……i"'5 
T S i i S i ^ " S S ; i I••••.8i" r i a 9 
M l M e S c h o S f277 [ 3 7 3 
•.诬函 .运 .。“[ \'fl5 f30"3 
' C o i l ^ e & A b o ^ [ l 4 5 \ ' \ 9 S 
At the time of interview, four hundred and eighty-three women (65.1%) have been 
employed and the rest (34.9%) of women have not been employed yet. The categories of 
jobs are shown in Table 1-3. Among the valid cases of seven hundred and five women, 
lower white-collar and factory workers made up two-thirds (34.8% and 33.6%, 
respectively). Of the women about one-fifth were employed in service jobs at shops or 
3 6 
markets at this moment or before they retired. Only 9.3% of women had had upper white-
collarjobs such as professors (Table 1-3). 
Table 1-3. Categories of Occupation for 705 *Valid Women 
Categories | No. of women i Percentage 
Ti^^G.WiiSe^:Wa^ I••…69 j••…9""8 
T C ( J ) ^ W i S ^ : ^ i ^ 1245 p34"8 
.iSi]^iiS^r"S^i^S; \l54 j'2T"8 
Blue-collar: Factory Workers | 237 | 33.6 
* Thirty-seven cases were user-missing data. 
The frequency of the procedures of utems and/or ovaries among 788 respondents is 
shown in Table 1-4. In all, 6.2% of respondents had had operations on their uterus and/or 
ovaries before the natural cessation of menses. About half of them only had a simple 
hysterectomy performed. 
Table 1-4. Frequency Table of Procedures on Utems or Ovaries for 788 Respondents 
Operation I No. of Cases I Percentage � 
i i i:. 
‘ • I 
Removal of One Ovary 6 0.8 
Removal ofUterus 25 3.2 
Removal ofUtems and One Ovary 15 i.9 丨丨 
Removal ofUterus and Both Ovaries I 3 6.4 
: : 
: : i I 
N^e f739 1•… '^"8 丨: 
Totai f788 i'ToO^ ‘ 
Among seven hundred and eighty-eight respondents, Forty-three women (5.5%) 
were defined as surgically postmenopausal. Three cases (0.4%) whose menstruation was 
stopped by taking some hormonal drugs were classified as drug-induced menopausal. Of 
the rest of seven hundred and forty-two women, two hundred and forty-two women were 
categorised as premenopausal, two hundred and forty women were defined as 
perimenopausal, and two hundred and sixty women were categorised as naturally 
postmenopausal (Table 1-5). 
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Table 1-5. Menopausal Status for 788 Respondents 
Menopausal status | No. of Cases | percentage 
Surgical Menopause I 43 5.5 
Drug-induced Menopause 3 0.4 
Premenopause | 242 | 30.7 
Perimenopause j 240 i 30.5 
Postmenopause j 260 I 33.0 
Totai [788 [ T 0 a 0 
Part Two: Age at Natural Menopause 
Age at natural menopause was identified by the time of final menstrual period for 
I 
260 naturally postmenopausal women. The mean age at natural menopause was 48.2 years 丨 
(SD=3.13) with the range of 38 to 55 years whereas the median age was 49 years. 
1. Reproductive History and Age at Menopause .^ 
1.1. Menstrual Factors (Table 2-1) ： 
！ 
Menstrual factors, including age at menarche, length and regularity of menstrual 
j 
period, and episodes of amenorrhea for six or more months during reproductive years were 
|), 
not found to be the influential factors on the age at natural menopause in this study. i' 
Table 2-1. Menstrual Factors and Age at Natural Menopause 0 
: i 
i No. of 丨 Age at 丨 
i i i ！ t 
Variable 丨 Natural i Natural t p , 
i Menopause j Menopause Value Value 
I ( n = 2 6 0 ) i (Mean) | 
" e T S f v S i t i ^ f i ^ : . . . a r i 4 3 i"48"0 1……'0.'75………|……0.456… 
>14 i 117 i 48.3 
J i i j 
Regularity: irreguiar I ^ | 47.6 0.97 丁 6.¾':^ 
i j I I 
Regular j 235 j 48.2 j 
! i i i 
- iSfei iSr i iSci^3S(i i^y^r^^ |••…96 \4SA j……"o.78………I……0.439… 
>28 I 139 i 48.1 
I i ！ j 
! ^ ^ . ^ f X i n i ^ ( i S i ^ r i ^ ) i i ^ I'226 i 48.2 1……‘0.09………：……0.929… 
i i i i 
Ever 丨 34 丨 48.2 







1.2. Pregnancy-related Factors 
The number of pregnancies and the age at first birth had not shown to affect the 
woman's age at natural cessation of menstruation. It was found that more parities 
corresponded with a later age at final menstrual period. The difference between two 
categories of parities (one group is less than or equal one livebirth. The other is more than 
one livebirth) is one year. However, the difference is not statistically significant Q)=0.061). 
Women who had ever breastfed had a delayed age at natural menopause for about one year 
than those women who had never breastfed any babies, but the difference was not 
significant (p=0.063). There was a trend that the more babies whom women had breastfed, 
the later age they experienced the cessation of menstruation. However, the trend is not 
statistically significant (F= 0.155) (Table 2-2). The total duration of breast feeding was 
found to be positively related to the age at the final menstrual period before adjusted for 
other factors (unadjusted p 二 0.019, p 二 0.0465). This means that the duration of breast-
feeding was prolonged one month, the age at cessation of menstruation delayed 0.02 years. 
The history of oral contraceptive use, regardless the duration of use, did not delay the age 
! 
at natural menopause in this study. 
I. 
I 
Table 2-2. Pregnancy-Related Factors and Age at Natural Menopause 
Variable j No. ofNatural | Age at Natural; 
I Menopause ! Menopause 丄飞 了 , \ ^ 了 ’ j, 
i ( n = 2 6 0 ) 丨（ M e a n ) | • � j p V a l u e |; 
•iS^ajiiii^.^i j•…91 [483 !……0.55 |……o7586…… 
>2 1 169 i 48.1 i I I, 
"Xie^.S.ii^rSBirS:-;^5S fT52 U S 2 1……"0.16 |……57872…… 丨 
>25 I 102 i 48.2 i I ‘ 
P^ t i e s : "< l !•…50 |'47'5 ；……T'.88 1……0706i..••••• 
>1 i 210 j 48.4 ! 
Bi^SiS^S"S^^&Birk&iSS3••••••|•…55 f47"5 1……i".'86 1……07063 
Breast-fed ] 205 j 48.4 
.•••S^aSi^fi^^.i [•…55 V47A j f 
1 丨 36 丨47.7 丨 1.76* i 0.155 
2 i 123 I 48.4 
3-4 i 46 i 48.6 | 
6.C. use: Neveir used 1193 148^ ；•……^ :^i^  1……石:@1……‘-
Used l__^ I 48.2 | | 
* One-way ANOVA and F value. 
• 
:.！ 
3 9 :;i 1 
• 
2. Socio-economic Factors and Age ofMenopause 
It was found that the higher monthly income was correlated with a later age at the 
final menstrual period while the income is treated as categorical variable. The difference 
of the time at cessation of menstruation between two groups was significant (p = 0.001) 
(Table 2-3). There was also a linear relation between the average monthly income in each 
100 Yuan and age at natural menopause (unadjusted p = 0.258, p = 0.0012). It means that 
income increased each 100 Yuan, the time of cessation of menses delayed 0.258 years. In 
another way of comparing income status, women whose monthly household income was 
increased, compared with those whose income stayed the same, their age at natural 
menopause was 1.3 years later (F = 0.01 in One-way ANOVA) (Table 2-3). 
f 
Living in an apartment, drinking milk or other calcium rich liquid, and 
participating physical activities were characteristic of higher socio-economic class. All i 
. . . 丨' 
these factors were correlated with delayed time at cessation of menstruation. However, i 
there were no significant differences of age at natural menopause between degrees of ； 
education, categories of occupation, sizes of house (p = 0.097, p = 0.091, and p = 0.074, 
i 
respectively) (Table 2-3) 
• i,' 
Table 2-3. Socio-economic Factors and Age at Natural Menopause 
Variable ;No.ofNatuHAgeatnatura l i 
i Menopause j Menopause 
i ^ = 2 6 0 ) j (Mean) | T value | P Value ：' 
Income per Month i | 
<500 R M B ! 129 I 47.5 | 3.40 I 0.001 |l 
>500 RMB h25 ! 48.8 '' ； i i • / 
Income Status ‘ 
No Changes | 82 | 47.3 
Decreased 丨 36 丨48.4 丨4.55* | 0.011** 
Increased 丨 142 丨 48.6 丨 | 
Housing Status 
House I 74 1 47.4 1 2.58 丨0.011 
Apartment i 186 | 48.5 
Supplement ofCaicium j | 
Never Taken j 141 j 47.8 | 2.33 j 0.021 
Has Taken | 62 丨 48.9 
Physical Activity 丨 丨 丨 j 
Never Engaged in ! 115 丨47.8 丨2.00 ! 0.046 
Engaged in | 144 | 48.5 | 
I 
40 
•.. 1 ;i.i 






i^  � 
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Level ofEducation 
Middle School or Less | 138 i 47.9 | 1.66 j 0.097 
High School or More | 122 | 48.5 | 
Categories of Job* 
Upper White-collar I 23 | 48.9 
Lower White-collar 1 79 1 48.3 | 2.18* 1 0.091 
Services | 43 I 48.4 
Workers | 95 | 47.4 | | 
Size ofHouse 
<9 Square meters | 103 | 47.8 | 1.80 | 0.074 
>9 Square meters | 157 | 48.5 | | 
* One-way ANOVA and F value. ** Between group 3 and group 1 
3. Nutrition and Habits 
i' 
The self-reported body weight, height, and calculated body mass index, regardless 
of the treatment of them as continuous or categorical variables, were not found to be 
related to the age at the final menstrual period (Table 2-4). Smoking and drinking also did ‘ 
not show relation to the age at natural menopause in this study. !; 
Table 2-4. Nutrition, Habits and Age at Natural Menopause 
Variable 丨 No. ofNaturai Age at natura; 
i Menopause i Menopause | T value j P Value |, 
丨 ^ 2 6 0 ^ i (Mean} 丨 丨 
Height(cm) I j 
<160 i 154 i 48.2 j 0.09 I 0.927 j^  
>160 I 105 I 48.2 , 
wdihtfe) I i t j 
<60 i 130 i 48.0 i 1.17 j 0.244 
>60 i 129 I 48.4 j 
B M I I j i j 
<24 i 120 i 47.9 I 1.54 | 0.124 
> 2 4 i 1 3 9 I 4 8 . 5 J | 
Smoking 丨 i i 丨 
Never Smoked | 243 | 48.2 | 1.01 | 0.312 
Smoked [ 17 | 47.4 | 
Drinking 
Does not Drink j 244 1 48.2 丨 0.42 丨 0.673 










4. Hormone Replacement Therapy and Marital Status 
Only one postmenopausal woman was single and a few of postmenopausal women 
(two cases) were taking hormone pills for climacteric symptoms. These numbers were too 
small to perform any test for the relationship between age at menopause and the marital 
status or the event ofhormone replacement therapy. 
Part Three: Symptoms Associated with Menopause 
All symptoms, which existed in the past two weeks preceding the interview, were 
grouped as vasomotor, psychological, and bone-joint symptoms 
1. Vasomotor Symptom 
1.1. Frequencies ofEach Symptom by Menopausal Status 
Hot flushes, cold sweats, palpitation, and headaches were classified as vasomotor ‘ 
symptoms. The prevalence of each symptom is shown in Table 3-1. 
The prevalence of hot flushes in perimenopausal women was the highest among 
three groups. It was the lowest one in premenopausal women. It was 25.9% among all 
respondents. The differences of prevalence between peri- and premenopausal groups and 
1, 
between peri- and postmenopausal women were very significant (both p<0.0001). There 
'i 
was still a significant difference between post- and premenopausal women (p=0.0247). 
The prevalence of night sweats in the peri- and postmenopausal group were almost 
the same ¢)=0.4734). Compared to the premenopausal women, both peri- and 
postmenopausal women had higher frequencies of cold sweats (both p<0.0001). The 
prevalence of palpitation and headaches were almost the same among all subjects. There 
was not any significant difference of reporting palpitation and headaches between 
menopausal groups. 
1.2. Vasomotor Symptom and Related Variables 
Before adjusted by any other factors, the women's age, body weight, and body 




vasomotor symptom (unadjusted OR=1.05, 1.02, and 1.06; p=0.0241, p=0.0103, and 
p=0.0100; respectively)(Table 3-2). 
Table 3-1. The Frequency ofVasomotor Symptoms by Menopausal Status 
Symptoms Pre- Peri- Post- Total 
l ！ • t . • • • 
. • j • 
• — • _ _ — _ • — 一 一 — _ • — • ••• — •• — •_ — — — _• — — • 一 iM 鍾睡 ~* _ _ — ~ _ _ • _ 一 — • _ — 一_ ——誦鍾一一一囲圓—一— 
• « : • 
丨 No. % 丨 No. % 丨 No. % 丨 No. % 
i (n=242) 丨（n = 2 4 0 ) 丨（n=260) ( n = 7 4 2 ) 
！ ！ • • 
• • j j 
Hot Flushes * I 27 (112) [ 91 (37.9) [ 74 (28.¾ | l92 (25.9) 
i i * • 
Night Sweats ** | 22 ( 9.1) | 62 (25.8) J 60 (23.1) [ 144 (19.4) 
Palpitation j 36 (14.¾ [ 53 (22A) I SS (22.3) [ l47 (19.8) 
j j I j j 
Headaches I 40 (16.5) I 59 (24.6) | 56 (21.5) | 155 (20.9) 
* x2(pre-, peri-) = 46.7 P=0.0000 ** X^prc-, pe r i - ) -23 .5 P=0.0000 
X^(pre-, post-)=23.4 P=0.0000 X%rQ-, post-)=17.9 P=0.0000 
X^(peri-, post-) =5.0 P=0.0247 x ^ e r i - , post-) =0.5 P=0.4734 
1 
Table 3-2 Logistic Regression Model for the Occurrence ofVasomotor Symptoms and 
Associated Continuous Variables 
Variables I Unadjusted OR I 95% CI ! P value : 
: ： i i 
"Age f i ^ 5 i T m ^ T m f ' a 6 ^ i 
" W e i i S f ' I ^ 2 l'Tm^lM f a 0 T 0 3 ； 
： ： ： i 
B M i [ 1 ^ 6 : T 6 i . ; . T n [o^Too ,' 
The prevalence of any vasomotor symptom was 44.5% among all respondents. It 
was related to menopausal status, number of parities, the events of psychological and 
bone-joint symptoms (Table 3-3). The differences of this prevalence between peri- and 
premenopausal groups as well as between post- and premenopausal women were very 
significant (both p<0.0001). There was also a significant difference between peri- and 
postmenopausal women (p=0.0440). Women with more parities had higher frequency than 
those women with one or no livebirth ¢)=0.0361). It was strongly associated with the 
existing ofboth psychological and bone-joint symptoms (both p<0.0001). 
4 3 
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Table 3-3 The Proportion ofVasomotor Symptoms by Related Categorical Variables 
‘ ^ ^ ^ ― I ‘ ‘ ‘ ‘ I I I ^ — 1 ‘ -^*¢^= j ^ ^ ― • I ^ 1 • I • “ __••• . . - — — ^ 
Variables 丨 Proportion 丨 x value j P value 
.iS i^^ ia;u^ S".i^ Siis:.Sr^ :.7iJ |28"T |..…41¾(!¾ 「 ^ ； : 丽 1 
Peri- (2) i 57.1 I 21.1(1,3) 1 <0.0001 
Post-(3) 丨48.1 丨 4 . i p ,3 ) i 0.0440 
P^tiesr<T l"39"9 [ I 
>1 1 47.7 4.4 j 0.0361 
Psychological Symptoms: No I 21.8 
Yes I 70.8 I 179.6 | <0.0001 
Bone-joint Symptoms: No | 26.4 
Yes 丨 63.8 | 105.1 I <0.0001 
1.3. Results in Multiple Logistic Regression Model 
After controlling for age, body mass index, and number of parities, the occurrence 
of vasomotor symptoms was associated with menopausal status and the existing of both 
psychological and bone-joint symptoms. Both peri- and postmenopausal women were 
•‘ I 
more than twice as likely to report vasomotor symptom as premenopausal women 
(adjusted OR = 2.50 and 2.17; p<0.0001 and p=0.0005; respectively). Women who 
complained of any psychological or bone-joint symptoms were about six times or three ；： 
times as likely to report vasomotor symptom than those who were not suffering from any 
psychological or bone-joint symptoms (adjusted OR = 6.19 and 2.62, respectively, both 
p<0.0001) (Table 3-4). 1-
Table 3-4. Multiple Logistic Regression Model for the Association between the 
Occurrence ofVasomotor Symptoms and Potential Influencing Factors 1, 
！ ！ ! 丨：. 
• • • 
• • • 
• J • 
Variables i Adjusted OR* j 95% C.I. j P Value '' 
• • * 
• • • 
• I I 
• j • 
Menopausal Status: Pre- j i.6o 
Peri- 1 2.50 I 1 .61,3.88 | <0.0001 
Post- 丨2.17 i 1.40,3.36 丨 0.0005 
Psychological Symptoms: No I i.6o 
Yes 丨6.19 i 4 3 2 , 8 . 8 8 丨<0.0001 
Bone-joint Symptoms: No i i.6fj 丨 
Yes i 2.62 | 1.84,3.75 | <O.QOQl 
^f . 
‘ * Odds radio of occurring vasomotor symptoms in past two weeks. 
Controlled by age, body mass index, and number of parities 









:: 2. Psychological Symptom 
A 
2.1. Frequencies by Menopausal Status 
Table 3-5 shows the frequencies of each psychological symptom, including 
'；•' 
depression, tiredness, insomnia, unconcentration and nervousness. 13.7% of the women 
reported depression. Insomnia was the most frequently occurring psychological symptoms. 
27.9% of the women reported insomnia. The prevalence of depression and insomnia were 
significantly different between peri- and both pre-, postmenopausal groups. The 
occurrence of unconcentration was statistically significant between peri- and 
premenopausal women ¢)=0.0010). There was no significant difference of the occurrences 
of tiredness, and nervousness between menopausal groups. 
Table 3-5. The Frequency ofPsychological Symptoms by Menopausal Status 
Symptoms Pre- Peri- Post- Total 
丨 No. % 丨 No. % 丨 No. % i No. % 
！ (n-242) 丨（n=240) j (n-260) (n=742) 
Depression * ! 2 9 ( 1 2 . 0 ) ！ 4 5 ( 1 8 . 8 ) ! 2 8 ( 1 0 . 8 ) j 1 0 2 ( 1 3 . 7 ) I 
. . . • • . . • . . . . • . . . . • • • • • • • • • • • • • • • - • • • - • • • • • • • • • • • • • • • • • • • • - • • • • • ^ • • • • • • • • • • • • • • • * . . . . . . . . . . . . . ¢ - . . . . ^ . . . . . . . . . . . . • . . . . • . , . . • . • . . . . . . . . . . , . . . . , I 
！ S ； i i 
Tiredness j 48 (19.8) | 65 (27.1) | 52 (20.0) [ 165 (22.2) 
Insomnia * * | 47 (19.4) | 94 (39.2) | 207 (27.9) | 207 (27.9) ； 
i : ： i I' 
: : ； ； I 
Unconcentration * * * | 25 (10.3) ！ 51 (21.3) | 41 (15.8) | 117 (15.8) |； 
Nervousness | 18 ( 7.4) | 31 (12.9) | 35 (13.5) | 84 (11.3) 丨 
,' 
* x2(pre-, peri-) =4.2 P= 0.0394 * * x ^ r e - , peri-) =22.7 P=0.0000 
X^er i - , post-) = 6.4 P=0.0116 x^(peri-, post-)=10.9 P=0.0010 
* * * X^(pre-, peri-) =10.8 P=0.0010 
2.2. Prevalence ofPsychological Symptom and Related Variables 
The prevalence of any psychological symptom was 46.2% among all subjects. This 
prevalence was related to menopausal status, relatives' health, occurrence of vasomotor or 















This prevalence was the highest among perimenopausal women while it was the 
lowest among premenopausal group. There were significant differences between 
menopausal groups. 
Women whose relatives had any occurrence of serious illness or death in the past 
twelve months preceding the interview experienced higher frequency of psychological 
disorders than those whose relatives were fine ¢)=0.0037). 
Each category of climacteric symptoms was strongly correlated to each other. 
Women who were bothered by vasomotor or bone-joint symptoms experienced 
psychological disorders as well (both p<0.0001). 
Table 3-6 The Proportion ofPsychological Symptoms by Related Categorical Variables 
； ； 2 ： Variables i Proportion i % value i P value 
Menopausal Status 
Pre- (1) I 34.7 | 28.9(1,2) | <0.0001 
Peri- (2) 丨59.2 5.5(1,3) 丨 0.0187 
Post- (3) I 45.0 I 10.0(2,3) 1 0.0015 丨, 
Reiatives or Friends Health 
Fine I 42.6 8.4 I 0.0037 
111 or Died | 54.1 ： 
Vasomotor Symptoms 
No I 24.3 1 179.6 | <0.0001 j' 
Yes 1 73.6 | | 丨 
Bone-joint Symptoms : 
No i 26.4 i 125.6 | <0.0001 '： 
Yes I 67.4 | | :': 
• ••• ^ ~ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ~ I I • • ^ ^ • ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ “ ^ ^ ^ ^ ^ ~ ~ " " ^ ^ ^ ^ ^ ^ ~ " ' ^ ^ ^ ^ ^ ~ ' " ' " " " ^ ^ ^ ^ ^ * " ^ ^ ^ ^ ^ " ~ ~ ^ ^ " ^ ^ J 
!,' 
I:'‘ 
. . / 
2.3. Results in Multiple Logistic Regression Model 
After adjusting for relatives' health and income status, Perimenopausal women 
were 60% more likely to report psychological symptom ( p = 0.0354). In contrast, 
postmenopausal women tended to be 10% less likely to report this kind of symptom than 
premenopausal women (jp = 0.6884). 
The symptoms themselves correlated to each other also. Women who were 
bothered by vasomotor or bone-joint symptoms were about six or four times respectively 












Table 3-7. Multiple Logistic Regression Model for the Association between the 
Occurrence of Psychological Symptoms and Potential Influencing Factors 
Variables | Adjusted OR* 1 95% C.I. | P Value 
Menopausal Status 
Pre- 1 1.00 
Peri- 丨1.59 | 1.03,2.47 丨 0.0354 
Post- I 0.91 I 0.59, 1.41 1 0.6884 
Vasomotor Symptoms 
No i 1.00 j 
Yes i 6.01 I 4.20,8.60 | <0.0001 
Bone-joint Symptoms 
No I 1.00 
Yes i 3.70 i 2.60, 5.26 | <Q.QQQ1 
* Odds radio of occurrence of psychological symptoms in past two weeks. 
Controlled by relatives' or friends' health and income status. 
First category of each variable is the reference group. 
3. Bone-joint complaints 
3.1. Prevalence of Each Symptom by Menopausal Status 
The bone-joint complaints, both backaches and joint problems, were most 
common. More than one-third of peri- and postmenopausal women experienced these two ‘ 
events (Table 3-8). The complaint of backaches among perimenopausal women was 
I� 
significantly higher than that of premenopausal group (P=0.0018). Compared with ：''' 
premenopausal women, both peri- and postmenopausal groups were more likely to 
if 
experience joint problems such as aches or stiffness in joints ¢)=0.0002 and p= 0.0012, ' 
r' 
respectively). 
Table 3-8. The Frequency ofBone-Joint Symptoms by Menopausal Status 
Symptoms Pre- Peri- Post- Total 
丨 No. % 丨 No. % 丨 No. % I No. % 
1 (n=242) j (n=240) | (n=260) | (n=742) 
Backache * | 68 (28.1) j 100 (41.7) | 94 (36 .2)丨 262 (35.3) 
� I : : ： 
J o i n t P r o b l e m s * * | 4 9 (20.2) | 85 (35.4) j 86 (33.1) | 220 (29.6) 
： * X ^ r e - , peri-) =9.8 P= 0.0018 **x^(pr&-, peri-)=13.8 P=0.0002 
； x V e - , post-)=10.5 P=0.0012 
1^ 
t*A 







3.2. Related Continuous Variables 
The increasing of body weight and body mass index were weakly and positively 
correlated with the occurrence of bone-joint symptoms (unadjusted OR=1.02 and 1.05; 
p=0.0428 and p=0.0291; respectively) before adjusted for other factors. 
3.3. Prevalence by Related Categorical Variables 
The prevalence of bone-joint symptom was 48.4% among all subjects. There were 
significant differences in the number of women complaining about bone-joint problems 
between peri- and premenopausal women as well as between post- and premenopausal 
groups ¢)=0.0001 and p=0.0007, respectively). However, there was no significant 
difference between peri- and postmenopausal women (p=0.4860). 
Women whose relatives or friends were seriously ill or died were more likely to 
experience this kind of symptom than those whose relatives were fine (p=0.0357). Women 
who were not employed or whose monthly income was decreased were more likely to 
complain it. Physical activity was inversely associated with the events of bone-joint 
problems (p=0.0452). Further analysis, there was no significant difference among the 
kinds of physical activities ¢)=0.4522). There were associations between the occurrence of | 
vasomotor, psychological symptoms and bone-joint symptoms (both p<0.0001) (Table 3-
9). i： 
！ 
Table 3-9 The Proportion of Bone-Joint Symptoms and Related Categorical Variables |； 
i 
_ ‘ ••丨••'• . S ‘ '•••••“ I _ — ^ ^ — ^ ― 
Variables i Proportion i x value I P value i! 
• j t I 
i i i I 
Menopausal Status 
Pre- (1) j 37.2 | 16.1(1,2) | 0.0001 ‘ 
Peri- (2) 丨55.4 1 11.6(1,3) 丨 0.0007 
Post- (3) i 52.3 i 
Relatives or Friends Health 
Fine | 45.8 4.4 | 0.0357 
111 or Died | 54.1 
Employment 
Has not been j 53.7 4.5 | 0.0349 
Has been i45.5 
. Income Status 
No Changed | 42.1 | 10.1(1,2) 丨 0.0015 
Decreased i 60.6 
: Increased 丨48.7 4.8(2,3) | 0.0289 
t Physical Activity i 丨 | 
r； Never Engaged in j 52.2 4.0 1 0.0452 








Kind of Activities 
Taiji or Qigong I 37.5 | 
Walking I 45.8 1.6 | 0.4522 
Dancing | 47.1 
Vasomotor Symptoms 
No 丨 31.6 丨 105.1 丨 <0.0001 
Yes I 69.4 I I 
« • • 
Psychological Symptoms 
No i 29.3 ! 125.6 1 <0.0001 
Yes j 70.6 I I 
3.4. Results in Multiple Logistic Regression Model 
While controlling for body mass index, relatives' health, menopausal status, and 
income status, it was discovered that women who have lived in apartments were 46% 
more likely to experience bone-joint problems than those women who have lived in houses 
(adjusted OR=1.46, 95% C.I.: 1.04，2.06, p=0.0310). Women who have participated 
physical activity were 36% less likely to complain about bone-joint problems (adjusted 
OR=0.64; 95% C.I.: 0.46, 0.89; p=0.0077). There were also associations among the ^ 
I 
categories of climacteric symptoms. Women who experienced vasomotor or psychological 丨 
|r 
symptoms were nearly three or four times as likely to complain about bone-joint problems |, 
i'' 
as well (adjusted OR= 2.82, 3.82, respectively, both p<0.0001) (Table 3-10). : 
]'•； 
Table 3-10. Multiple Logistic Regression Model for the Association between the ‘ 
Occurrence ofBone-Joint Symptoms and Potential Influencing Factors 丨 
I I j 1^  
; : : .' 
Variables | Adjusted OR! 95% C.I. | P Value ' 
Housing Status: House I i.00 
Apartment 丨1.46 丨1-04,2.06 j 0.0310 
Physical Activity: Never Engaged inj i.00 
Has Engaged in | 0.64 ] 0.46,0.89 ！ 0.0077 
Vasomotor Symptoms: No 丨 L6iii j 
Yes [2.82 [ l.98, 4.03 | <0.0001 
Psychological Symptoms: No I 1.00 
Yes I 3.82 | 2.68, 5.45 | <0.0001 
* Odds radio of occurrence ofbone-joint symptoms in past two weeks. 
Controlled by menopausal status, BMI, relatives' health, and income status. 
First category of each group is the reference group. 
： 4 9 
^ 
4. Climacteric Symptoms 
Overall, it was found that perimenopausal women experienced the most frequent 
climacteric symptoms with 86.3% stating they had. Premenopausal women were the 
lowest with 58.3% claiming they had. 73.1% of the postmenopausal group experienced 
climacteric symptoms. The occurrences of climacteric symptoms between any two 
menopausal groups were significant. When it was adjusted by number of parities, 
relatives' health, and job satisfaction, it was found that perimenopausal women were 3.7 
times as great as premenopausal women to experience any climacteric symptoms (adjusted 
OR=3.69, 95% CI: 2.20, 6.19, and p<0.0001) whereas postmenopausal women tended to 
be 1.6 times as likely to report them than premenopausal women (adjusted OR 二 1.58, 
95% CI: 0.98, 2.55, and p 二 0.0606). i 
’• 
Part Four: Disturbance in Sexuality 
[. 
The analysis of the variables relating to sexuality included 484 sexually ( 
active women who had sex at least once per month in the past three months preceding the “ 
interview. The data of 258 sexually inactive women who had sex less than once a month in 
! 






1. The Proportion of Sexually Active Women j-
'/; 'fi 
1.1. Proportion by Related Categorical Variables / 
Women who had sex at least once per month in the past three months preceding the 
interview were defined as sexually active. The proportions of sexually active are shown, 
by menopausal groups and other correlated categorical variables, in Table 4-1. 66.4% of 
all respondents had sex at least once per month. Following menopausal transition, this 
proportions of women decreased. There were significant differences in this proportions 
between any two menopausal groups. Increases in the number of pregnancies, parities, and 
babies breastfed, correlated to a decrease in this proportion. It was positively related to the 
satisfaction rate on contraceptive methods ¢)=0.0139). Significantly lower proportions 




lowest category of occupation, and who had a decreased monthly income. Women who 
had smoked were also less likely to be sexually active. (Table 4-1). 
Table 4-1. The Proportion of Sexually Active Women by Related Categorical Variables 
Variables 1 Proportion j x value | P value 
Menopausal Status 
Pre- (1) i 81.4 4.5(1,2) | 0.0345 
Peri- (2) 丨73.2 | 64.9(1,3) 丨<0.0001 
Post- (3) 丨46.3 丨 37.1(:2,3) 丨<0.0001 
Pregnancies 
<2 i 73.6 I 12.4 | 0.0004 
>2 I 61.2 i i 
Parities 
<1 丨 77.0 I 25.6 丨 <0.0001 
>1 丨 59.0 : I ^ •[ {• h }' 
Babies Breast Fed 
< 1 I 72.4 丨 13.9 丨 0.0002 ；^ 
>1 i 59.3 i i ； 
Satisfied on Methods 
No i 84.0 1 6.1 I 0.0139 丨: 
Yes I 95.5 1 [ ( 
Level ofEducation 
MiddleSchoolorLess | 60.1 | 13.0 | 0.0003 ： 
High School or More i 72.6 
Employment 
Not Been 丨5 1 . 8 I 37.0 丨 < 0 . 0 0 0 1 ‘“ 
Has Been 丨74.1 ；： 
• • • f,. 
Job Categories j i 丨;(丨 
Upper White-collar | 73.9 8.1(1,4) | 0.0045 f: 
Lower White-collar I 74.8 | 20.9(2,4) I <0.0001 | | 
Blue-collar (Service) | 74.0 | 14.7(3,4) j 0.0001 / 
Factory Workers j 54.7 
Income Status 
No Changed (1) | 64.3 | 
Decreased (2) | 57.0 6.6(1,3) | 0.0103 
Increased (3) 丨 70.1 
Smoking 
Never Smoked i 67.4 5.4 | 0.0205 
Smoked | 50.0 j I 
The major reason for a lack of sexual activity was a loss of interest. The number of 
women who reported a lack of sexual desire among pre-, peri-, and postmenopausal 
women were 34.1%, 54.7%, and 59.4%, respectively. 




There was a weakly negative association between proportions of women having 
sex at least once per month and age as well as the duration of breastfeeding. Positive 
associations were found between sexual activity and both age at first birth and years of 
education (Table 4-2). 
Table 4-2. Logistic Regression Model for the Association between the Proportion of 
Sexually Active Women and Potential Related Continuous Variables 
Variables I Unadjusted OR 1 95% CI j P value 
Age j0"82 ! 0 7 8 7 ^ 8 6 !'<6：0061 
..^ 涵“雨^^ 涵“ •^••..•|"0：98 jO"97;'a99 「 ^ ； ： 臓 
.ge.Sfi^SBSS l"lA3 \T-09jJ9 |<6：0^1 
—r‘.^ (^i“(^ a^ (^^ i^  t"T"l4 [l"097ll9 [<0^ 001 
1.3. Results in Multiple Logistic Regression Model / 
While controlling for menopausal status, reproductive factors, socio-economic 
t 
variables, and smoking in multiple logistic regression model, it was found that sexual 
activity was related to satisfaction on contraceptive methods. Women who were satisfied 
with their contraceptive methods were 5 times as likely as those were not satisfied it to . 




2. The Proportion ofEnjoyable Sexual Activity p 
|fi_ 
The sexual function and disturbance in sex were assayed only among sexually 丨 
' \ 
active women. The occurrences of enjoyment, orgasm, vaginal dryness and painful 1； 
1^  
intercourse at the frequency of at least half or more occasions of intercourse were \ 
t' 
categorised as frequent. 
2.1. Proportion by Related Categorical Variables 
The percentages of women who enjoyed their sexual activities at least half the time 
in the three months preceding the interview are shown, by menopausal status and other 
correlated variables, in Table 4-3. This proportion decreased during menopause and it was 
61.7% among all assayed women. Peri-, and postmenopausal women were less likely to 
enjoy their sex than premenopausal women (p=0.0010 and p<0.0001, respectively). The 
number of parities was inversely related to this proportion. There was also a correlation 
between the occurrence of vasomotor symptoms and this proportion. Negative correlation 




Women from higher socio-economic classes, as indicated by higher level of education, 
employed, increased income, and/or supplement of dietary calcium, had a frequent 
reporting of enjoyable sexual activity. Smoking was inversely related to this proportion 
(Table 4-3). 
Table 4-3 The Proportion of Women Who Enjoyed Their Sexual Activities at Least Half 
the Time the Three Months by Preceding the Interview by Related Categorical Variables 
Variables | Proportion 1 x value 1 P value 
Menopausal Status 
Pre- (1) I 73.4 j 10.8(1,2) | 0.0010 
Peri- (2) 丨57.1 丨 18.2(1,3) 丨 < 0 厕 1 
Post- (3) I 49.6 I i 
Parities 
<1 I 67.5 I 6.3 I 0.0122 ( 
>1 j 56.5 i i I 
Vasomotor Symptoms ” 
No i 65.6 4.1 I 0.0419 丨 
Yes 丨 56.5 , 
,•••••••• •..••....•<；•••••••>••.••••••••••••• r*>** • • • • { • • • • • • • » • • • • • • • • • • • • _ • • • • • • • • • • • • • • • • _ » • • • • • • • • » h 
Vaginal Dryness 丨 
< Halfthe Time I 65.8 I 24.8 | < 0 . 0 0 0 1 
> Halfthe Time | 32.2 | (: 
PainM Intercourse I .; 
< Halfthe Time I 64.7 j 24.6 j <0.0001 � 
> Halfthe Time | 21.2 | 丨 
^ ^ 4> 1 
Level of Education 1 |^ , 
Middle School or Less 1 56.0 5.6 | 0.0184 L 
High School or More j 66.4 | j 丨  
Employment Status :'；' 
Not Employed 丨52.7 6.2 | 0.0126 ；,： 
！ i • ••' 
Employed | 65.1 I I 
Income Status ' 
No Changed 丨 57.4 丨 
Decreased | 50.8 5.3(2,3) | 0.0218 
Increased j 66.4 
Supplement of Calcium 
Never Taken j 55.6 7.8 ! 0.0051 
Has Taken | 70.1 j 
Smoking 
Never Smoked 丨63.2 丨 10.2 丨 0.0014 
Smoked | 28.6 | | 
2.2. Related Continuous Variables 
The frequency of women reporting enjoyment of sex at least half the time in the 




breastfeeding. There was weak, positive correlation between the age at first birth, years of 
education, monthly income and this proportion (Table 4-4). 
Table 4-4 Logistic Regression Model for the Association between the Proportion of 
Women Who Have Enjoyed Their Sexual Activities at Least Half the Time in the Three 
Months Preceding the Interview and Related Continuous Variables 
Variables | Unadjusted OR | 95% CI ^^ ^^ |^ P value 
Aie"geSs) r0"90 |"0"8576"96 [0^008 
— e . S . S S i i ^ S ^ ^ f0"88 f6"80r0"97 f o ^ T S 
'iSuii5iS'ST&Sii]i<irui)SfisJj|••_•�i5:^ [o"97rroo �iJi^ii^^ 
• • X ^ S f i i S ^ i i r S _ ^ — f L 0 8 \ l m J " i 3 ["0^065 
• ^ ^ ^ • • 丽 ^ 3 1 ^ ( 好 竭 j L i o ilM^Lvi j'o^oTis 
—ii^y"i^i^bi^S_(ii'66"S^&j r"l.09 l T m ^ h i 9 r"0^361 
y ii 
2.3. Results in Multiple Logistic Regression Model ^ 
,t. 
t: 
While controlling for all the correlated variables in the multiple logistic regression 丨 
model, it was found that peri- and postmenopausal women were about half less likely to 
enjoy sexual activity than premenopausal women. Women who experienced frequent 
vaginal dryness and/or pain were more than 60% less likely to enjoy sexual activity at half 
or more time. It was also found that when the years of education increased by one year, the 丨‘ 
proportion of women who enjoyed their sexual activity at half or more time increased by ； 
；''/' 
13%. Supplementing dietary calcium was positively correlated with the occurrence of 丨 
：'''' . . • i'； 
enjoyable sexual activity (Table 4-5). |:! 
:P 
Table 4-5. Multiple Logistic Regression Model for the Association between the Frequency i ; 
丨,丨’ 
of the Proportion of Women Who Have Enjoyed Their Sexual Activities at Least Half the ‘ 
Time in the Three Months Preceding the Interview and Potential Influencing Factors , 
Variables j Adjusted OR* | 9 5 % C . I . | “ P V a l u e ^ 
• • i • • * 
• • • 
Menopausai Status: Pre- I 1.00 
Peri- 丨 0.47 j 0.28,0.79 丨 0.0044 
Post- i 0.46 丨 0.26,0.82 丨 0.0092 
Vaginal Dryness: < Half the f ime j 1.66 
> Halfthe Time | 0.37 | 0.15,0.95 | 0.0391 
Painftil Intercourse: < Half the f ime ： i.o6 
> Halfthe Time | 0.34 | 0.10, 1.14 丨 0.0794 
Years "of S S u c a S d : - g S ; � \ L \ 3 { !"05^Tj2 f'aOOOS 
SuppiementofCalcium:]^evertatenil.i)6 丨 




* Odds ratio of frequently enjoying sexual activities 
Controlled by age, reproductive factors, vasomotor symptoms, some of socio-economic 
factors, and smoking. 
First category of each variable is considered as the reference group. 
3. The Proportion ofWomen Reporting Orgasms 
3.1. Proportion by Related Categorical Variables 
The proportion of women reporting orgasms at least half the time they had sex in 
the three months preceding the interview is shown, by menopausal status and other related 
categorical variables, in Table 4-6. It was 54.1% among all sexually active women. This 
proportion was negatively related to menopausal status and the frequency of experiencing 
/ 
vaginal dryness and/or pain. Women who were employed or were supplied calcium | 
I 
experienced frequent orgasms (p=0.0082 and p=0.0085, respectively)(Table 4-6). f 
Table 4-6. The Proportion of Women Who Have Experienced Orgasms at Least Half the 
Time They Engaged in Sex in the Three Months Preceding the Interview by Related 
Categorical Variables 
Variables | Proportion 1 x value j P value ( 
Menopausal Status : 
Pre- (1) ！ 65.6 9.5(1,2) | 0.0020 ’ 
Peri- (2) 丨49.7 丨 16.7(1,3) 丨<0.0001 
Post- (3) 丨 42.0 丨 
Vaginal Dryness i !；：• 
< Halfthe Time ! 56.9 1 11.1 | 0.0009 :� 
> Halfthe Time | 33.9 f 
i !• : j |丨丨 
Painful Intercourse 设 
< Halfthe Time I 56.7 j 18.4 | <0.0001 / 
> Halfthe Time | 18.2 
Employment Status 
Not Employed | 44.3 7.0 I 0.0082 
Employed i 57.7 
Supplement of Calcium 
Never Taken 1 49.6 6.9 | 0.0085 
Has Taken j 63.5 
3.2. Related Continuous Variables 
There were negative correlation between the proportion of women reporting they 
have orgasms at least half the time they have sex and age, age at menarche and the 
duration of breastfeeding. This proportion was also positively related to the age at first 
birth, years of education, and monthly income (Table 4-7). 
丨 5 5 
• i :j 
m 
Table 4-7 Logistic Regression Model for the Association between the Proportion of 
Women Who Have Experienced Orgasms at Least Half the Time They Engaged in Sex in 
the Three Months Preceding the Interview and Related Continuous Variables 
Variables j Unadjusted OR j 95% CI I P value 
••X^e"�@s� ro"96 jo"85r6"96 j"0"0006 
• X ^ S . i ^ i i ^ i ^ ^ ^ s > jo!96 f a 8 3 r i " 2 0 [0"0403 
T i3 i i iS i i i ^ rST5SaSSr ( i ^SSs ) " [ f j : ^ ['0"98^1^0 � i 5 : i S ^ 
• X ^ S i i ^ S B S S . ^ e ^ r g \ " \ M f T 6 i ^ T T i ' f0"0352 
. . % ; S l c i ] ( ^ a H ; ^ e ^ a i ^ j i |'T!08 ] l m ^ l J 4 j'0'0079 
�^^y" i in^b^nS( i . ^ .Y i j iS j • • • • • . |T" i i \ l m J 2 i j"o"oTQ5 
3.3. Results in Multiple Logistic Regression Model 
Multiple logistic regression analysis demonstrated that the reporting of frequent f 
I 
orgasms for peri- and postmenopausal women was about 60% less than that of 
r 
premenopausal women. Women who were bothered by frequent vaginal dryness were 70% 
less likely to experience frequent orgasms. There was positive correlation between the : 
frequency of orgasms and years of education and supplement of calcium (p=0.0072 and : 
p=0.0057, respectively) (Table 4-8). 
(‘ 
Table 4-8. Multiple Logistic Regression Model for the Association between the ‘ 
Proportion of Women Who Have Experienced Orgasms at Least Half the Time They 
Engaged in Sex in the Three Months Preceding the Interview and Potential Influencing , 
Factors |,. 
Variables I Adjusted j 9 5 % C . I . i P V a l u e “ I':: 
丨 O R * 丨 丨 丨；: 
； ； i I 
Menopausal Status: Pre- j 1.00 ；} 
Peri- j 0.43 j 0.26,0.71 | 0.0009 :: 
Post- I 0.39 i 0.22,0.69 丨0.0013 � 
Vaginal Dryness: < Half the Time i 1.00 
> Halfthe Time | 0.26 | 0.12, 0.57 ！ 0.0008 
： J : 
• • • 
！ i i 
Years ofEducation (years) ； 1.10 | 1.03, 1.18 i 0.0072 
Supplement of Calcium: Never Taken I 1.00 
Has Taken | 1.97 | 1.22,3.20 | 0.0057 
* Odds radio of women who have experienced orgasms at least half the time they engaged 
in sex in the three months preceding the interview. 
Controlled by age, reproductive factors, frequency of painful intercourse, and some 
socio-economic factors. 
First category ofeach variable is considered as the reference group. 
丨 5 6 
, 
4. The Proportion of Women Who Experienced Vaginal Dryness 
4.1. Proportion by Related Categorical Variables 
The proportion of women experiencing vaginal dryness at least half of their sexual 
intercourse is shown, by menopausal status and other related variables, in Table 4-9. These 
proportions were increasing common during menopause. The differences between any two 
groups were statistically significant, especially between post- and premenopausal women 
(^<0.0001). Increased parities were correlated to a frequent vaginal dryness (p=0.0003). 
This proportion was also positively related to the existence of climacteric symptoms as 
well as the individual categories of symptoms. It was also inversely correlated with the 
frequencies of enjoying sex and/or experiencing orgasms. Surprisingly, women were 
employed in higher job categories and supplied dietary calcium reported frequent vaginal | 
I 
dryness. Higher frequency of vaginal dryness was related to decreased income j: 
^)=0.0102)(Table 4-9). 
Table 4-9. The Proportion of Women Who have Experienced Vaginal Dryness at Least i 
Half the Time They Engaged in Sex in the Three Months Preceding the Interview by , 
Related Categorical Variables 
^ = ^ = ^ ^ = ^ ^ = ^ ^ = ^ = ^ ^ ^ ^ ^ = i = ^ ^ ^ ^ = p = = ^ ^ ^ ^ ^ ^ = i 
Variables 1 Proportion I x value ! P value 
Menopausal Status ； 
Pre- (1) ! 3.6 | 9.1(1,2) I 0.0026 j；； 
Peri- (2) ! 12.0 丨 34.4(1,3) 丨<0.0001 丨：丨. 
Post- (3) I 26.1 I 9.^2,3) | 0.0019 ！； 
Parities | j j | ^ 
<1 i 6.5 j 13.1 I 0.0003 / 
>1 I 17.3 丨 j 
Climacteric Symptoms 
No 丨 5.8 7.4 丨 0.0064 
Yes 1 14.7 
Vasomotor Symptoms 
No i 7.5 I 13.1 i 0.0003 
Yes 1 18.4 
Psychological Symptoms 
No i 8.3 7.9 I 0.0051 
Yes i 16.7 丨 
Bone-joint Symptoms 
No i 8.7 6.0 i 0.0140 






< Halfthe Time | 21.5 I 24.8 I <0.0001 
> Halfthe Time | 6.3 
Proportion of Orgasms 
< Halfthe Time j 17.5 1 11.1 | 0.0009 
> Halfthe Time j 7.6 
Job Categories 
Upper White-collar 丨21.6 丨 7.7(1,4) 丨 0.0057 
Lower White-collar 1 14.4 
Service | 10.5 | 3.9(2,4) 丨 0.0476 
Workers | 7.1 | | 
Supplement of Calcium 
No i 8.3 7.3 i 0.0068 
Yes i 17.5 j I 
— r r / 
Income Status 丨 丨 “�, 
No Changed | 7.4 6.6(1,2) | 0.0102 广' 
Decreased j 19.7 ；• 
Increased | 13.0 | | 
�, 
4.2. Related Continuous Variables ( 
Woman's age, years of education, and size of house in square meters were : 
positively correlated with the frequency of experiencing vaginal dryness during sexual 
activities (Table 4-10). 
Table 4-10 Logistic Regression Model for the Association between the Proportion of |,; 
Women Who have Experienced Vaginal Dryness at Least Half the Time They Engaged in 丨,) 
Sex in the Three Months Preceding the Interview and Related Continuous Variables | : 
Variables | Unadjusted OR 1 95% CI | P value i'^  
i : i / 
j I j ,» 
A i e ' g e S s ) [T'25 [ l J s J ^ [ < a M 6 l 
• . % r . ^ “ g ^ ( — g !T:Ti I ' T m ^ T ^ j•…o.''oi'77 
••妬口.贷“¥¥“.[石巧……�rii^ ri"6T7rT2 1••••.0'Ql""39 
4.3. Results in Multiple Logistic Regression Model 
Using the multiple logistic regression model, vaginal dryness was discovered to be 





5. The Proportion ofPainful Intercourse 
5.1. Proportion by Related Categorical Variables 
The proportion of women who reported pain at least half of all sexual intercourse 
in the three months preceding the interview is shown in Table 4-11. It was 6.8% among all 
assayed women. This proportion among postmenopausal was significantly higher than 
either peri- or premenopausal groups. There was positive correlation between this 
frequency and the occurrences of climacteric symptoms, or vasomotor and bone-joint 
symptoms. This frequency was inversely correlated to the frequency of enjoyment and 
orgasms. Women who had higher levels of education were more likely to report pain 
during sexual activities (Table 4-11). 
/ 
Table 4-11. The Proportion of Women Who Experienced Pain at Least Half of All Sexual | 
Activities During the Three Months Preceding the Interview by Related Categorical ：丨 
Variables i 
Variables j Proportion j j^ value |~~P value •• 
i i I r/ 
Menopausai Status 
Pre- (1) i 2.6 ,, 
Peri- (2) | 5.1 i 18.4(1,3) ！ 0.0002 :', 
Post-(3) ！ 16.0 9.6(2,3) | 0.0019 |' 
Climacteric Symptoms ! i I 1,¾; 
No I 2.9 1 4.7 i 0.0300 :, 
Yes 1 8.4 i ', 
i i- 4 ,j| 
Vasomotor Symptoms 丨： 
N o I 4 . 7 I 4 . 7 1 0 . 0 3 0 2 [J； 
Yes 丨 9.7 丨 i ":, 
4 1 / 
Bone-joint Symptoms ‘ 
No i 4.3 5.1 j 0.0241 
Yes j 9.5 j 1 
Proportion ofEnjoyment 
< Halfthe Time I 14.0 j 24.6 j <0.0001 
> Halfthe Time | 2.3 
Proportion of Orgasms 
< Halfthe Time | 12.1 j 18.4 ; <0.0001 
> Halfthe Time | 2.3 
Level ofEducation 
Middle School or Less | 3.7 6.1 j 0.0137 







5.2. Related Continuous Variables 
The frequency of painful intercourse was positively related to age and the size of 
the home in square meters (unadjusted OR=1.25, 1.08, and p=0.0001 and p=0.0148, 
respectively). 
5.3. Results in Multiple Logistic Regression Model 
After adjusted for all correlated variables, it was discovered that frequency of pain 
experiences was only related to the occurrence of orgasms. Women who experienced 
frequent orgasms were more than 90% less likely to be bothered by pain at least half the 










1. Prevalence by Menopausal Status 
The prevalence of common disorders, including diabetes, hypertension, heart 
!... ‘f 
disease, bone fractures, arthritis or rheumatism, cholecystitis or cholelithiasis, vagintis, 丨 
• ':‘丨 
and urethritis or cystitis, is shown by menopausal status in Table 5-1. Hypertension, heart , 
|i;" 
disease, and arthritis were the most common ones, with 15.6% of women suffering from | ;Z] 
V 
hypertension, 10.9% from heart disease, and 12.4% from arthritis. Bone fracture was the "� 
'r 
least frequent one with 0.9% among the listed disorders. Most of the disorders became ,/ 
increasingly prevalent during menopause; however, only the differences of heart disease 
and arthritis were significant between the menopausal groups (p=0.0039 and p=0.0076, 
respectively). 
Table 5-1. The Prevalence ofListed Common Disorders by Menopausal Status 
I Pre^ i Peri- | Post- I Total 
Disorders 丨 丨 丨 i 
丨 N % 丨 N % 丨 N % 丨 N % 
[ (n=242) i (n=240) | (n-260) | (n=742) 
Diabetes [ 2 ( 0.8) | 8 ( 3.3) [ 4 ( 1.5) | 14 ( 1.9) 





Heart disease * 丨16 ( 6 . 6 ) 丨 24 (10 .0 )丨 41 (15.8)丨 81 (10.9) 
Fracture I 3 ( 1.2) 1 ( 0.4) | 3 ( 1.2) | 7 ( 0.9) 
Arthritis ** | 27 (11.2) | 20 ( 8.3) | 45 (17.3) | 92 (12.4) 
Cholecystitis | 11 (4.5) | 13 ( 5.4) | 17 ( 6.5) | 41 ( 5.5) 
Vagintis | 3 (1.2) j 5 ( 2.1) j 12 ( 4.6) ! 20 ( 2.7) 
Urethritis | 3 (1.2) | 3 ( 1.2) 1 5 ( 1.5) 1 11 ( 1.5) 
* X^=11.1 P=0.0039 ** x^=9.S P=0.0076 ^ 
lr* *f 
I 
2. Prevalence ofFractures ！ 
i\ 
There was no significant difference in the prevalence ofbone fractures between age 
groups or menopausal groups in this sample (p=0.7979 and p=0.5877, respectively). The � 
number of parities or babies breast-fed, oral contraceptive use, and reproductive years, 
were not correlated to the occurrence of fractures. However, the length of the menstrual 丨 
i 
cycle in days was inversely correlated with the prevalence of fractures (unadjusted OR= i' 
I ( ‘ 
0.73; 95% C.I.: 0.54, 0.97; p=0.0319). Socio-economic class, as represented by level of ' 
'V 
education, monthly income, and the use of dietary calcium supplements, was not ' 
''ii IV' 
correlated with the prevalence of fractures. Smoking, drinking, physical activity, and a 丨 
I I 
i'.> 
family history of fractures were also not related to the occurrence of fractures (Table 5-2). 
r' 
Body mass index was positively related to the prevalence of fractures (unadjusted 
OR=1.29; 95% C.I.: 1.02, 1.64; p=0.0365). 
Table 5-2. The Prevalence ofFracture by Associated Categorical Variables 
• • 2. • Variables I Proportion i x value i P value 
& e 丨 丨 f 
45-49 i 0.9 I 0.1 i 0.7979 
50-54 I 0.8 
Menopausal Status 
Pre- (1) 丨 1.2 1 
Peri- (2) | 0.4 | 1.1 | 0.5877 
Post- (3) [j_2 1 J 
i 
I 






<1 1 1.6 I 2.6 I 0.1065 
>1 I 0.5 i i 
Babies Breast Fed 
< 1 I 0.7 I 0.4 I 0 . 5 3 1 3 
>1 1 1.2 i 
' a c 7 u s e j ! I 
Never Used j 0.9 | 0.1 1 0.7134 
Used 1 1.2 j j 
Reproductive Years 
<34 j 0.8 i 0.4 I 0.5300 
>34 i 1.6 I ！ 
"j V 
Level of Education 
Middle School or Less | 0.5 j 1.3 | 0.2606 , 
. • j / 
High School or More | 1.3 [ | ! 
Monthly Income | | | 丨: 
< 500 RMB I 0.5 j 1.6 | 0.2126 ！？ 
> 500 RMB 1 1.4 
Supplement of Calcium 
Never Taken 丨1.0 丨0.4 丨0.5333 丨 
Has Taken j 0.5 | ( 
Smoking i 丨 
Never Smoked | 1.0 | 0.4 [ 0.5150 丨； 
Smoked | 0.0 
Drinking 
Does not Drink ! 0.9 i 0.5 | 0.4977 
Drinks j 1.8 | | :; 
Physical Activity i ;;|) 
Never Engaged in 丨1.1 丨0.2 丨0.6593 |, 
Engaged in I 0.8 '::� 
Family History of Fractures i / 
No : 1.1 i 0.1 I 0.7623 
Yes | _ ^ 1 1 
3. Prevalence ofHeart Disease 
The prevalence of heart disease increased following menopause. Only the 
difference between post- and premenopausal groups was statistically significant 
^F=0.0012). The number of parities was positively correlated with this prevalence 
¢)=0.0112). The number ofbabies breastfed, use of oral contraceptives, and the duration of 
reproductive years were not related to its occurrence. Socio-economic status was also not 
correlated with this prevalence. Personal habits, including smoking, drinking and physical 




correlated with this prevalence (p=0.0471) (Table 5-3). However, when the body mass 
index was treated as a continuous variable, the relationship was not significant (OR=1.06, 
95% C.I.: 0.99, 1.14, p=0.0836). This prevalence was positively related to age (unadjusted 
0R=1.12, 95% C.I.: 1.04, 1.20; p=0.0015). 
Table 5-3. The Prevalence ofHeart Diseases by Associated Categorical Variables 
Variables | Proportion i % value i P value 
Menopausai Status 
Pre- (1) 丨 6.6 丨 
Peri- (2) | 10.8 丨 10.4(1,3) 丨0.0012 
Post-(3) i 15.8 I 3.7(2,3) 丨0.0553 
Parities i 丨 ； 
<1 I 7.5 6.4 I 0.0112 / 
>1 i l 3 :4 i 丨 （^  
Babies Breast Fed 1 :,, 
<1 丨 8.9 I 3.8 1 0.0522 丨 
>1 i 13.4 I I ； 
""ac7Use ! i I 丨 
Never Used | 10.5 0.5 j 0.4739 丨 
Used 丨 12.4 丨 （ 
Reproductive Years , 
<34 1 14.3 i 0.3 I 0.5961 ：‘ 
>34 |16.7 1 i 
Level of Education ., 
Middle School or Less I 10.3 0.3 i 0.5911 丨： 
t • : j 'i,. 
High School or More j 11.5 丨： 
Monthiy Income i |;^  
< 500 RMB ！ 10.6 0.0 | 0.8940 1, 
> 500 RMB i 10.9 1'^ ' ^ - i. / 
Supplement of Calcium ’ 
Never Taken 1 11.3 0.1 | 0.8128 
Has Taken | 11.9 
Smoking 丨 
Never Smoked | 10.6 1.5 | 0.2186 
Smoked | 16.7 
Drinking j 
Does not Drink | 10.8 0.2 1 0.6927 
Drinks | 12.5 | 
Physical Activity 
Never Engaged in 1 10.2 0.4 1 0.5449 
Engaged in j 11.6 
Body Mass Index i 
^ 2 4 丨 8.5 1 3.9 丨 0 . 0 4 7 1 




After controlling for menopausal status, the number of parities, duration of 
breastfeeding, and body mass index, age persisted to be related with the occurrence of 
heart disease (adjusted 0R=1.12; 95% C.I.: 1.04, 1.20; p-0.0015). 
4. Prevalence of Arthritis 
The differences of the prevalence of arthritis between peri- and premenopausal, as 
well as between post- and perimenopausal women, were statistically significant (p=0.0495 
and p=0.0029, respectively). Women who had more numbers of livebirths were more 
likely to suffer from arthritis (p=0.0378). None of associations was found between the 
occurrence of arthritis and number of babies breastfed, oral contraceptive use, or 
categories of reproductive years. Women with higher incomes were less likely to suffer 
/ 
from arthritis than women with lower incomes (p=0.0255). Increase in each 100 Yuan of , 
I 
income per person was correlated to 10 percent decreased in the occurrence of arthritis ):( 
t 
(OR=0.89; 95% C.I.: 0.79, 1.00; p=0.0421). Other socio-economic factors were not 
related to this prevalence. Smoking and physical activity were also not associated with it. 丨 
However, women who had consumed alcohol at least once a week only had one-third of ( 
the prevalence of that women who had never consumed any alcohol (p=0.0371). Age and 
body mass index were not correlated to its occurrence (Table 5-4). 
Table 5-4. The Prevalence of Arthritis by Associated Categorical Variables ,., 
Variables | Proportion | x^ value | P value ：,；" 
s • l I 
: : : i i‘ • 丨 丨 ';'l . “ . i^j," 
- ¾ ; 1 1 丨 丨； 
45-49 I 11.6 i 0.4 I 0.5103 |):> 
50-54 I 13.3 / 
Menopausal Status 
Pre- (1) i 11.2 
Peri- (2) I 8.3 3.9(1,2) | 0.0495 
Post- (3) I 17.3 [ 8.^2,3) 1 0.0029 
Parities 
<1 1 9.4 4.3 I 0.0378 
>1 ] 14.5 
Babies Breast Fed 
<1 I 10.9 1.9 1 0.1644 
>1 i 14.2 丨 i 
" a c 7 u s e j f I 
Never Used i 13.1 1.1 | 0.2936 








< 3 4 丨 18.8 0.4 丨 0 . 5 3 4 8 
>34 i 15.9 I 
Level of Education 
Middle School or Less | 10.3 3.0 | 0.0842 
High School or More 丨 14.5 
Monthly Income 
< 500 RMB 1 14.6 5.0 | 0.0255 
> 500 RMB j 9.2 | | 
Supplement of Calcium 
Never Taken 1 12.5 0.9 j 0.3409 
Has Taken j 9.8 | | 
Smoking 
Never Smoked I 12.1 0.7 ! 0.3876 
• ； • ^ 
Smoked | 16.7 j |^ . 
Drinking j I ? 
DoesnotDrink | 13.1 I 4.3 I 0.0371 ?• 
• • I I 
Drinks 3.6 j 
Physical Activity 
Never Engaged in 1 13.0 0.2 | 0.6469 
Engaged in j 11.9 
Body Mass Index 
<24 1 10.8 i 1.6 1 0.2084 v 
>24 I 13.9 I I 
When controlled for the number of parities and drinking habit, it was found that the 
I'；, 
postmenopausal women were 88% more likely to experience arthritis than premenopausal 丨  
. ''''' 
women. It was also found that for each 100 Yuan increase in the monthly income was 丨〜! 
j ; i : / 
correlated to 10 per cent decreased in the prevalence of arthritis. / 
Table 5-5. Multiple Logistic Regression Model for the Occurrence of Arthritis and 
the Potential Influencing Factors 
Variables | Adjusted OR* j^ "^95 % C. I. | P Value 
Menopausal Status 
Pre- 丨 1.00 i 
Peri- I 0.78 | 0.41, 1.46 1 0.4371 
Post- 丨1.88 1 1.10,3.20 i 0.0209 
"i^iiSSfylin^bSniyi"^ri^^__]ai^3 「15了为「^5:的 [ ' 6 ^ 3 8 1 
* Odds ratio of occurrence of arthritis. 
Controlled by the number of parities and drinking habit. 
First category of each variable is considered as the reference group. 
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Part Six: Contraceptive Status 
The data analysis of contraceptive status was archived among 313 current 
users of contraceptive methods among pre- and perimenopausal women. The current users 
were defined as those who had used any methods for contraception in the previous 12 
months preceding the interview. The non-users and postmenopausal women as well as the 
single women were treated as the system-missing data. 
1. Frequency of Contraceptive Women 
Contraceptive status was assayed only among premenopausal and perimenopausal 
women in the twelve months preceding the interview. 75.6% of two hundred and forty- � 
1^  
two premenopausal women, 54.2% of two hundred and forty perimenopausal women, and ;‘; 
'•t~i r 
64.9% of all assayed women, had used some form of contraception. 16.2% of women had : 
I • 
not used any form of contraception. 18.9% of both premenopausal and perimenopausal 
|i' ！ 
I 
women had not had sexual intercourse. , 
i: 
2. Prevalence of Contraceptive Methods Used 
•1 ‘ 
The primary forms of contraception the women had used were intrauterine device 
(IUD) and barrier method. The minor methods used were sterilisation and natural method 
by the rates of 18.2% and 13.1% among assayed women. Oral contraceptive use was at the 丨 
;ii 
lowest prevalence of 3.5% (Table 6-1). The prevalence of each contraceptive method used :::; 
:丨〔丨 
between pre- and perimenopausal women was not significantly different. ;):' 
./ 
Table 6-1. Types of Contraceptive Methods Used by Pre- and Perimenopausal Women 
Menopausal Status Pre- Peri- j Row Total 
i N % ! N % j N % 
i (n=183) I (n=130) | (n=313) 
Oral Contraceptive 8 (4.4) | 3 (2.3) [ 11 (3.5) 
Intrauterine Device | 70 (38.3) | 54 (41.5) | 124 (39.6) 
Barrier Method | 47 (25.7) | 33 (25.4)丨 80 (25.6) 
Natural Method | 28 (15.3) | 13 (10.0) j 41 (13.1) 




3. Efficacy of Each Method 
Only two of one hundred and twenty-four IUD users and three of eighty barrier 
users became pregnant during the previous twelve months. The effective rates for IUD and 
barrier method were 98.4% and 96.3%, respectively. The effective rates of other methods, 
including oral contraceptives, natural method and sterilisation, were one hundred per cent 
during the twelve months preceding the interview (Table 6-2). The differences of efficacy 
between the methods were not significant. The effective rates for pre- and perimenopausal 
women almost were the same (98.4% and 98.5%, respectively). 
Table 6-2. Efficacy of Each Method in the past 12 Months 
Method j Number of Users ! Number of Users ! Efficacy 
1 Being Pregnant ； (percentage) 一' 
I j I - I 
1 (n=313) 丨 （n=5) 丨 （n=313) :“ 
^ .^ _ • • • • • • « • • « • • _ • • • • • • • • • • • • • . • • • _ • • • • • • • _ • • • • • » . _ • _ • • • • • • I 
OralContracegtive | 11 0 | 100.0 
： ： ： 11 
_ ‘ • 1 
Intrauterine Device i 124 2 1 98.4 , 
\ \ 1 I 
Barrier Method ! 80 3 1 96.3 ： 
. • . .’_i ‘ 
Natural Method | 41 0 | 100.0 
i 丨 丨 'f 
Sterilisation I 57 0 j 100.0 
_ • ‘ • i,__ 
), 
•,i‘ 
Chi-square test: %^  = 4.3. P = 0.3687 丨: 
:A 
4. Advantages by Methods , 
No women taking oral contraceptives (OCs) complained about this method. 
Almost half (45.5%) of OC users were satisfied it due to its high efficacy. Another 45.5% 
was satisfied because it had no noticeable side-effects. 
Forty percent of the IUD users considered its high efficacy. Other reported 
advantages were its harmless to woman's health and its simple use. 12.0% of IUD users 
complained about side-effects, such as heavy bleeding, spotting, and backaches. 
Among barrier group, more than one-thirds of users considered them high 
effective. Almost another one-thirds of users chose them due to their simplicity. 20.0% of 
users liked them because of a lack ofharmful side effects. However, 12.5% ofbarrier users 




O f t h e women using natural contraception, 41.5% of women chose it as its ease of 
use. 29.3% of users considered it an effective method and 22.0% of users chose it because 
of no side-effects. The most common complaint from women using natural method was 
that it affected sexual activity because of nervousness and fear of pregnancy. 
All procedures of sterilisation, both male and female, were performed during 
woman's twenties and thirties. The largest reported benefit of sterilisation was the high 
efficacy. The other major reported benefits were no side-effects and simplicity. Fewer 
women complained of disadvantages (Table 6-3). 
Table 6-3. Advantages ofEach Method in the past 12 Months 
Advantage 1 O.C. | IUDs i Condom | Natural | Sterili- Total 
I 丨 Method i zation , 
— • • • — — • • 一 _ — « _ _ — _ — • _ — _ _ • » — • • — • — • • • • • — _ • _ • _ _ • • • • • — — — — — • _ _ — — — • • — — — — ! \ ， 
: N % | N % : N % | N % : N % 1 N % •‘ 
" f f i ^ ; 了 ' 阴 : 穷 - 「 ^ " ( 恥 两 了 双 ( 诉 : 6 厂 口 … … • ^ ^ ： 环 - 口 ？ 兩 了 终 - ; ] ^ … ( ^ : " ^ ; … f: 
Efficacy 丨 丨 丨 丨 丨 丨 丨 
NoSMe-•••••-j-y-^Gy--i--^-(^-:^-pK(5i5:fjyT$••…•^^^…「•!^••(妨了办-广-力••…(沒：-巧… 
e f f e c t s I j i i I j ' ' ' ' 
Easyto ^ Y J ^ ^ ' ' ^ ^ ^ ^ … （( 
U s e ： ： ： ： ： i , 
CompiaiS^T0••…(-6:^-i-jy(j"5:^_|"j;6(j;i:^_j••…3••…(y^yl••…4"(6-^''T'"32••…(10.0)"' ：‘ 
‘ I ‘ 
5. Satisfaction ；;； 
;ii 
5.1. Satisfaction Rates by Methods 
( 
,/,1丨 
The satisfaction rates of each method are shown in Table 6-4. The satisfaction rates ’ 
/ 
for women using OC, sterilisation, natural method and IUD insertion were higher than for 
barrier users. No significant differences of satisfaction rates were found among groups of 
methods (p=0.5546) (Table 6-4). 
Table 6-4. Satisfaction Rates ofEach Method in the past 12 Months 
Method “ = j Not S a t i s f i ^ ~ ^ ^ " Satisfied " ^ 1"""" Total 
IN % I N % I N % 
i.••...•....••(n=26)… 丨 （n=293) 丨（ n = 3 1 $ 
6rai Contraceptives 丨（i ( 0.0) | ii' "('l60"0)••…j••••.Tl' ( "3"¾ 
Intrauterine Device 丨 i i ( 8.8) Vl l3 (91:¾…-\ \24 (33:¾ 
BOTie^s 1••…9 (11"¾ I••…71 (88'S)••••.f •-80 (25¾) 
亟 燕 = 二 二 二 二 二 : ] ] = : : = : : 西 I 38 (¾;?)••…I••…41 (13"i') 
. |S ter iH^^on “ j 2 '('3.6) |…55 (96'4)"|••…57 (18.2) 
�“Chi-square t st: < = 3.0 P=0.5546 ‘ “ 
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5.2. Factors Influencing Satisfaction 
To determine which factors affected the satisfaction rate for contraceptive methods, 
the correlation between satisfaction and potential variables were examined. It was found 
that age was positively related to satisfaction rate (unadjusted 0R=1.41, 95% C.I.: 1.07, 
1.84, and p=0.0130). Menopausal status was accounted for the difference in satisfaction 
(^=0.0175). Perimenopausal women were less likely to satisfied the methods. Women 
with more parities were more likely to satisfy their methods than those with one or no 
parity (p=0.0183). However, frequencies of enjoying sex or orgasms, vaginal dryness 
and/or pain, socio-economic status, and body mass index were not correlated with the 
satisfaction rates for the methods (Table 6-5). 
y 
Table 6-5. Satisfaction Rate and Potential Influencing Variables ,^  
F = ^ ^ = ^ = = = = p = = = _ = ^ ^ = 搏 
Variables j Proportion ; x value 1 P value :«； 
Menopausal Status ‘ 
Pre- I 95.1 | 5.6 j 0.0175 
Peri- i 87.7 
4 |> j. ‘ 
No of Parities 
< 1 丨88.6 丨5.6 j 0.0183 丨： 
> 1 I 95.8 1 , 
. . .w . . . . . . . . . . . ^ • • • • _ ‘ • . • • • • _ . • • • • . • • • • • • • • • • • • • . , . , . . • • • • • 1 
Proportion ofEnjoyment 
< Halfthe Time I 90.3 | 1.5 | 0.2231 
> Halfthe Time ! 94.2 
i j^  ： 
Proportion of 6rgasms 
< Halfthe Time 1 90.4 1 1.9 I 0.1698 '； 
> Halfthe Time 194.6 •;” 
: ： ； ,‘‘ 
Vaginal Dryness y 
< Halfthe Time j 93.6 | :: 
> Halfthe Time [ 82.4 | 3.1 | 0.0765 , 
PainfUl Intercourse 
< Halfthe Time j 93.5 j 3.3 1 0.0692 
> Halfthe Time | 77.8 | 
Levei ofEducation [ 
Middle School or Less | 92.5 j 0.1 I 0.7117 
High School or More j 91.3 
Monthly Income | 
< 500 RMB I 91.0 1 0.3 j 0.5944 
> 500 RMB ! 92.6 
• • ； 
Suppiement ofCalcium j 
Never Taken 1 93.9 丨2.9 1 0.0900 
• i j 
Has Taken j 87.8 
Body Mass Index i 丨 
<24 丨 89.1 I 3.1 丨 0.0794 
>24 j 94.5 : : : 
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6. Factors Related to the Choice of Contraception 
6.1. Oral Contraceptives 
There was no correlation between choice of oral contraceptives and age group, 
menopausal status, or number of livebirths. It was not related to the frequency of sexual 
activities. It was not correlated with the socio-economic class. No association was also 
found between the body mass index(BMI) and this choice (Table 6-6). 
Table 6-6 Choice of Oral Contraceptives and Potential Influencing Variables 
Variables ! Proportion ! x value 1 P value 
^ e i i i 
45-49 i 3.0 I 1.4 I 0.2348 ^ 
50-54 1 6.4 i (, i |. 5'/i 
Menopausal Status : 
Pre- I 4.4 | 1.0 } 0.3285 ;-
Peri- i 2.3 I 
： I 二 ’ 
Parities 
<1 i 4.0 I 0.4 i 0.5516 丨：’ 
>1 i 2.8 1 i r 
Frequency of Intercourse 
l -2TimesPerMonth i 3.3 1 0.1 | 0.7234 ; 
>2 Times Per Month | 2.6 
Level of Education 
Middle School or Less ! 4.8 I 1.5 | 0.2261 '' 
High School or More j 2.3 | | ；';• 
Monthly Income I , ii 
< 500 RMB 1 2.4 | 1.2 j 0.2694 '； 
> 500 RMB i 4.7 1 !；^  
‘ > • 
Supplement of Calcium / 
Never Taken | 3.7 | 0.4 | 0.5307 
Has Taken i 2.2 
Body Mass Index 
<24 i 5.1 1 2.6 i 0.1077 
>24 [ 0 I 1 
6.2. Intrauterine Device 
The proportions ofIUD users by menopausal groups and other variables are shown 
in Table 6-7. The number of parities was correlated with the choice of IUD insertion. 
Women who had only one parity were more likely to choose insertion of IUDs than 
women who had two or more parities ¢)=0.0004). There was a positive correlation 
between the frequency of monthly intercourse and the proportion of women choosing 
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IUDs (p=0.0104). The choice o f IUDs was not related to age, menopausal status, level of 
education, monthly income, or body mass index (P>0.05). 
Table 6-7. Choice ofIntrauterine Devices and Potential Influencing Variables 
Variables | Proportion I x value | P value 
"e" I I I 
45-49 I 41.0 i 2.1 j 0.1477 
50-54 1 29.8 
Menopausai Status 
Pre- 丨 38.3 丨 0.3 丨 0.5579 
Peri- I 41.5 
Parities 丨 丨 
< 1 丨 48.0 丨 12.6 丨 0 . 0 0 0 4 
>1 I 28.5 I I / 
Frequency ofIntercourse I 1 $ 
1-2 Times Per Month | 33.9 j 6.6 j 0.0104 |, 
>2 Times Per Month | 48.7 丨 
Level ofEducation 
Middle School or Less | 41.1 | 0.4 | 0.5207 •' 
High School or More j 37.6 | | ' 
Monthiy Income ( 
< 500 RMB I 42.8 I 1.7 i 0.1916 丨 
> 500 RMB i 35.6 ；‘ 
Supplement of Calcium 
Never Taken 丨33.5 丨 3.6 丨0.0588 
Has Taken | 45.6 1 
Body Mass Index '' 
<24 丨 42.3 i 1.2 j 0.2637 ‘：丨：丨 
>24 i 36.2 丨 丨 '丨, 
I ！ ： 丨々  
," 
6.3. Barrier Method 
The proportions of barrier users are shown by menopausal status and other 
potential variables in Table 6-8. The same as IUD group, the choice of barrier use was 
affected by the number of parities of woman had. Women who had only one parity were 
more likely to choose barrier method than women had two or more parities (p=0.0039). 
The correlation between this choice and the frequency of monthly intercourse was the 
opposite of the IUD group. There was a negative relation of sexual activity to the 
frequency of women choosing barrier method ¢)=0.0115). But, there were no any 






Table 6-8 Choice ofBarriers and Potential Influencing Variables 
Variables | Proportion | % value | P value 
“ e " I I • • • • • • • • • I 
4 5 - 4 9 丨 26.6 丨 1.9 丨 0 . 1 6 3 7 
50-54 I 17.0 1 
Menopausai Status 
Pre- j 25.7 j 0.0 | 0.9524 
Peri- I 25.4 
Parities 
< 1 丨 31.4 ! 8.3 丨 0 . 0 0 3 9 
>1 1 17.4 I I 
Frequency ofIntercourse 
1-2 Times Per Month 丨 30.1 丨 6.4 丨 0.0115 
>2 Times Per Month j 17.1 | / 
Level ofEducation 丨 p 
Middle School or Less | 20.5 | 2.9 1 0.0864 ；. 
High School or More | 28.9 丨 丨 丨 
Monthly Income 
< 500 RMB I 25.9 | 0.2 1 0.6202 丨: 
> 500 RMB i 23.5 卜 
4 i 1 ,_ 
Supplement of Calcium 
Never Taken 1 27.4 ： 1.2 I 0.2665 ‘ 
； ； ； I 
Has Taken 丨21.1 i 
Body Mass Index 
< 2 4 1 25.0 I 0.0 i 0.9748 ,； 
>24 i 25.2 i ； ； ； 
r,: 
‘i) 
6.4. Natural Method : 
|.:V 
s-
The percentages of women who chose natural method by menopausal groups and , ' 
other factors are shown on Table 6-9. This choice was not significantly related to age, 
menopausal status, number of parities, or frequency of intercourse. There was no 
correlation between the choice of natural method and level of education, use of calcium 
supplements, or categories of body mass index (P>0.05). However, there was a correlation 
between monthly income and the percentage of women who chose this method. Women 
from higher income group were more likely to use natural method for contraception than 
those from lower income group ¢)=0.0394) (Table 6-9). 
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Table 6-9. Choice ofNatural Contraception and Potential Influencing Variables 
Variables | Proportion | % value ： P value 
" ^ e i I I 
4 5 - 4 9 丨 12.2 丨 0.8 | 0 . 3 6 0 3 
50-54 i 17.0 
Menopausal Status 
Pre- 1 15.3 | 1.9 | 0.1708 
Peri- 1 10.0 
Parities 
<1 j 10.3 j 2.3 j 0.1310 
>1 i 16.0 I I 
Frequency of Intercourse 
1-2 Times Per Month j 14.2 | 0.3 | 0.5774 
>2 Times Per Month i 12.0 | j , 
Level of Education ! § 
Middle School or Less | 11.6 | 0.4 | 0.5534 : 
High School or More | 13.9 | 
Monthly Income 
< 500 RMB I 9.0 i 4.2 1 0.0394 
> 500 RMB I 16.8 
.4............... •••^•••••••^••••••••••••••••••着 •. •. •. •... .^  
Supplement of Calcium 
Never Taken I 11.6 1 0.2 I 0.6840 
丨 丨 丨 ’./• 
Has Taken | 13.3 
Body Mass Index 
<24 丨11.5 丨0.5 i 0.4926 ,„ 
>24 h 4 J 1 I 
I ： 
'i'" 
Since all sterilisation procedures were performed during the women's twenties and ” 
. :^¾ 
thirties, there was no reason to explore the potential factors in the choice of sterilisation 




Chapter Four: Discussion 
Part One: Age at Natural Menopause 
1. Distribution of Age at Natural Menopause 
1.1. Studies in the Asian Countries 
The mean age at natural menopause estimated from our study was consistent with 
those found in other studies in the Asian countries. The mean age at natural menopause in 
Asian countries was around 48.5 years ranging from 44.0 to 50.7 years. This is comparable 
with 48.2 years found in the sample of 742 Chinese women ages of 45 to 55 years in our : 
n 
study. In particular, this age in a survey among perimenopausal Chinese women in Beijing : 
'., 
was 49 years (23). It was 44 years among the Philippines from a survey carried out before 
1985 (24), and 48 years from a recent survey of Philippine women (25). It was 49.5 years 
in a sample of Thai women living in the Bangkok area (26); 50.5 years in Indonesian 
women in urban areas (27); 50.7 years in the Malaysian women (13% Chinese, 70% 
Malays and 16% Indians) (28); 46.2 years in women living in Turkey (29); 50.2 years in 
Japanese women (30). 
1.2. Studies in the Western Countries 
1 ： 
The mean age at natural menopause estimated from our study was lower than the 
median ages obtained from the studies in the Western countries. The median age at ！》 
menopause in most Westem industrialised societies has been shown to be remarkably 
constantly around 51 years, ranging from 50.0 to 51.4 years (3, 15-22). For example, The 
age at natural menopause occurred at 51.3 years from 5 years of follow-up of 2,570 
women in Massachusetts who were aged 45-55 years (17). It was 51 years estimated from 
a sample of Finnish women aged 45-64 years (19). This difference may be a complex 
effect ofhereditary, cultural and socio-economic factors on the age at natural menopause. 
2. Factors Influencing Age at Natural Menopause 
Menopause happens when ovulation is exhausted (10). Therefore, any factors that 
affect ovarian function may influence the age at natural menopause. 






2.1.1. Menstrual Factors 
The lack of an association between age at menarche and age at menopause 
observed in our study is consistent with findings from most of other studies (15, 26, 31-
34). 
A few studies have examined the relation between menstrual cycle characteristics 
and menopausal age (15,18,35). A prospective study and a case-control study have shown 
the association between length of menstrual cycle and age of menopause. The prospective 
study indicated they were linearly related: each 1-day increase in median cycle length was 
related to a 10 percent decrease in the odds of ceasing menstruation after adjusting for 
parity and age at menarche (15). The case-control study (344 cases aged at menopause 
being 42.2 years and 344 age-matched controls still menstruating or menopausal after age :: 
I 
46 years) found that cases significantly had shorter cycle lengths than the controls (35). :; 
i.:,' 
These findings are compatible with the physiology of the menopause that 
menopause occurs after sufficient depletion of oocytes. Thus more rapid oocyte loss is 
related to the earlier onset of menopause (35). 
However, we found no such association. This may be due partly to the variation of 
'i . 
menstrual variables. The length of the menstrual cycles is changeable itself over the all 
period of the reproductive years, the ability to recall menstrual cycle intervals was 
'丨.. 
considered unreliable (208). � . 
f ； 
2.1.2. Pregnancy-related Factors :fi 
:.,丨; 
One study suggested that women who had ever been pregnant reached menopause A 
slightly, but statistically significantly later than women who had never been pregnant (15). 
This was however not confirmed in another study (32), neither did the relationship exist in 
our data. 
Several previous studies reported that parous women have menopause at a later age 
compared with nulliparous women (18, 37-39). However, there was too few nulliparous 
subjects in this study to allow to examine this association. 
Our study confirmed the previous report that no association between age at first 
birth and age at final menstrual period (31). 
Women with more parities had a delayed age at natural menopause. We found that 
women with parities of two or more had a later age at the final menstrual period for one 
year than those with fewer parities. This was also documented by another large study (18). 
75 
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,| In order to understand link between parity and the age at cessation of menstruation, 
it is useful to review the ovarian function during pregnancy. The pattern of gonadotropin 
secretion is governed by the negative and positive feedback actions of ovarian oestrogen 
(209). It was found that amount of oestrogen is increased produced in the fetoplacental 
unit during pregnancy (210). Ovulation is inhibited by the high level of oestrogen in the 
way of feedback to the central nerves of pituitary-gonadal axis during pregnancy (209). 
The more full-term pregnant women had ever been, endocrinically, the longer duration of 
anovulation had been; clinically, the later cessation of menstruation occurred. 
On the other hand, there is also an association between the number of parities and 
the socio-economic status. The socio-economic status is positively related to the age at 
natural menopause. Parity is generally inversely related to the socio-economic status. In '' 
M" 
. . ^ our study women who had parities of two or more had fewer years of education (10.0 
':,, 
versus 11.3 years, p < 0.001) and less income (463.6 versus 501.8 Yuan, p = 0.029) 
compared with those who had fewer parities. Consequently, the effect of parities on the 
age at natural menopause may be underestimated in our study. 
Women who had ever breastfed had a delayed age at natural menopause. In our 
study, women who had ever breastfed tend to have natural menopause about one year later 
than those who had never breastfed ¢)=0.063). There was also a trend that the more babies 
a woman had breastfed, the later cessation of menstruation occurred. The duration of , 
'•； 
breastfeeding and age at menopause was linearly related: 1-month increase in the duration 
'.彳丨 
ofbreastfeeding was associated with 0.02 years delay in the onset of menopause. 丨, 
{'• > 
Why does breastfeeding cause delay in age at natural menopause? After ,' 
parturition, prolactin level drops, but rise temporally during the feeding hours because of 
the stimulation of the breasts, which leads to release of prolactin. Follicle-stimulating 
hormone (FSH) will rise slowly. WMle prolactin is high and FSH is rising, the ovarian 
function is not restored (211). Ultrasound studies show the absence of follicle 
development during lactation. Clinically, by the end of the third month, only 33% of 
lactating women have had a menstrual period, whereas 91% of nonlactating women have 
had at least one period. The hormone assays show that among women menstruating before 
6 months of postpartum, 67% of cycles were anovulatory, and the lag between anovulatory 




suppresses ovulation, might be expected to delay the time of the final menstrual period 
(212). 
The estimates of the effect of breastfeeding on the age at menopause may be 
confounded by the socio-economic status. There is an association between the number of 
babies breastfed and the socio-economic classes. Women with history of breastfeeding for 
more than one baby had fewer years of education (9.7 versus 11.3 years, p < 0.001) and 
less income as well (463.6 versus 501.8 Yuan, p = 0.029) than those women who had ever 
breastfed for less baby. 
2.1.3. Hormone Use 
Oral contraceptive use was not related to the age at natural menopause in our 
study. This is consistent with the finding of another investigation (16). ;: 
I 
The role of hormone replacement therapy can not be explored since the number of ‘ 
women who were postmenopausal and also had used hormone were too small in this 
study. 
2.2. Socio-economic Factors and Nutrition 
Women of higher socio-economic status had a later age at natural menopause. Of 
(• 
all potential influencing factors, socio-economic factor is most consistently related to the 
age at the onset of menopause. Women who were in the higher income group were 1.3 
years later cessation of menstruation (p = 0.001). It was also found that the age of natural 
), 
menopause came 1.3 years later in women whose monthly income was increased than ;: 
those whose incomes stayed unchanged. We found that living in apartments, drinking milk :> 
and taking physical activities were all associated with delayed age at cessation of 
menstruation in our study. It is probably because these women living in apartments had 
more years of education (11.2 versus 9.5 years, p<0.001) and also had higher monthly 
income (524.0 versus 402.3 Yuan, p<0.001) than those women living in single-story 
houses. Women taking any dietary calcium had more years of education (11.4 versus 9.9 
years, p<0.001) and higher income as well (535.3 versus 437.0 Yuan, p<0.001). Physically 
active women tend to have more years of education and higher income. 
Several pervious studies have shown that certain environmental factors that affect 
ovulation indirectly during reproductive years may ultimately influence the menopause 
(16, 18, 19, 29, 31, 32). The mechanism is unclear. It is likely that socio-economic factors 




with malnutrition were at later age of menarche (30) and earlier age at menopause than 
women with better nutrition (3). Malnutrition even causes the infertility. 
Body weight, height and derived body mass index (BMI) were not consistently 
related to the time of the final menstrual period. One Japanese study showed that body 
weight positively correlated with age at menopause (30). The self-reported body weight, 
height and derived body mass index (BMI) were not found to be related to the time of the 
final menstrual period in our study. In a recent study in Finland (19), for body mass index, 
none of the tests was significant for the difference of the median age at natural menopause. 
In contrast, it was found that obese women reached menopause on average 1.7 years 
earlier than women with chronic energy deficiency (29). 
Body weight, height and body mass index are affected by the hereditary factors, '' 
v< '0' 
socio-economic factors and individual behaviours. Nowadays, there is not a certain 
-V 
association between the nutrition and body weight and body mass index. 
2.3. Smoking 
Smoking influences the age at natural menopause. Smoking as a potential factor on 
the age of menopause was consistently demonstrated in several pervious studies (16，17, 
19, 36, 38, 39, 42). The smokers had an earlier age at natural menopause than non-
smokers. Among the smokers, the age of menopause is also negatively correlated to the 
number of cigarettes. 
Smoking had not shown to correlated to the age at natural menopause in this study. ,;'i 
','； 
Within our data, the cases of postmenopausal women who smoked are only 17 persons, ,¾ 
including both ex-smokers and current smokers. Our data did not provide an optimal ‘ 
situation for evaluating the smoking effect on natural menopause. 
Part Two: Symptoms Associated with the Menopause 
1. Vasomotor Symptom 




The frequency of hot flushes was lower among the Asian women than that among 
the Westem women. In our study the frequency of hot flushes was 25.9%. Lower 
occurrences were also found among Chinese women in two previous studies. A survey of 
Chinese factory workers in Fujian found that only 18% of women experienced hot flushes 
(72). Another survey on Chinese women in Hong Kong showed that hot flush was 
reported in 10% (73). However, In a multicentre study, 34% of Canadian had complained 
this symptom (13). A prospective survey involving Ghanaian women found that hot flush 
was reported by 56.5% of women (57). In a community-based population of Caucasian 
women in California, 74% of them reported hot flushes (65). 
1.2. Hot Flushes and Menopausal Status 
/ 
Hot flush is a true menopausal symptom. In this study, the differences of reporting S 
.( 
hot flushes between any two menopausal groups were significant. Our finding of hot 
flushes relating to the menopausal transition is consistent with the results from the most 
pervious studies (50，51, 55, 62, 76). The investigators consistently found that hot flushes 
emerged as a true menopausal symptom and it is clearly associated with the menopausal 
transition. 
1.3. Frequency of Vasomotor Symptom 
The frequency of vasomotor symptom differs from the study populations. The 
frequency of at least one vasomotor symptom among postmenopausal women was 48.1%, -: 
i . 
and it was 44.5% for all respondents in our study. This is close to the reported rate o f40% >^  
.," 
in the Sweden postmenopausal women (70), but lower than that of Filipino women at the 
rate of63% (25). 
1.4. Vasomotor Symptom and Menopausal Status 
Vasomotor symptom was best predicted solely by menopausal status. In this study, 
the differences of vasomotor symptom between any two menopausal groups were 
significant. Both peri- and postmenopausal women were more than twice as likely to have 
vasomotor symptoms as premenopausal women. These findings were similar to previous 
studies. Holte and co-workers showed that vasomotor complaint was the only variable 
significantly related to menopausal development (51). Kaufert found that a significant 




also showed that only vasomotor symptoms were significantly related to menopausal 
status (52). Hunter demonstrated that vasomotor symptoms were best predicted solely by 
menopausal status (53). 
2. Psychological Symptom 
2.1. Frequency ofDepression 
The prevalence of depression differs from the study populations. It was 13.7% 
among all subjects in our study. Similarly, 13% of the women were diagnosed having 
depression among 390 climacteric patients of Japanese (66). A community-based study of 
589 Caucasian in California reported that depression was recalled by one-fifth of women 
!*• 
(65). It was much higher among the participants attending menopause clinic; 65% having ): 
varying degrees of depression (67). '' 
2.2. Depression and Menopausal Status 
The prevalence of depression is associated with the menopausal status, probably 
because the development of depression is due to the estrogen deficiency. This inference 
was evidenced by three previous studies (62-64) as well as our study. These investigators 
claimed a clear positive trend of menopausal status with the prevalence of depression. 
Although some other studies failed to find the association (59-61). , 
2.3. Psychological Symptom and Menopause ;:: 
,¾ 
Psychological disorder is related to menopausal status but the time relationship was '\, 
not the same association as vasomotor symptom. In our study, perimenopausal women 
were 60% more likely to experience psychological symptom, but postmenopausal women 
were tended to be 10% less likely to experience this kind of symptoms than 
premenopausal group. This relationship between occurrence of psychological disorders 
and onset of menopause obtained from our study is consistent with other two previous 
studies. A survey showed an increase in psychiatric morbidity starting before the 
menopause and lasting until about one year after menstrual periods had ended (68). 
Another study found that irritability, excitability，depression and poor concentration 
improved after cessation of menstruation (50). 




Physical activity is inversely associated with the frequency of bone-joint problems. 
In our study, women who lived in apartments were more likely to experience bone-joint 
symptoms than those women who lived in single-story houses. Women who lived in 
apartment generally were of higher socio-economic class. For example, women living in 
apartments had not only more years of education (11.2 versus 9.5 Years, p < 0.001) but 
also higher income (524.0 versus 402.3 Yuan, p < 0.001) than those who lived in houses. 
Women living in apartments were more likely to be employed as white-collar workers 
than those living in house (53.6% versus 29.0%, p<0.0001). White-collar workers were 
sedentary for longer time than blue-collar workers. Several previous studies consistently 
showed that both sedentary premenopausal and sedentary postmenopausal women had a 
decreased bone mineral density (BMD) compared to physically active ones (214-218). Our ' 
、对 i^l 
study also found that women who have participated physical activity were less likely to 
(( 
experience bone-joint problems. Most bone-joint complaints were due to osteoporosis and 
osteoarthritis. It was consistently found that physical activity was a protective factor on 
reducing the risk of bone loss in middle aged women (219-221). Therefore, there was a 
reduced prevalence ofbone-joint symptoms among physically active women. 
4. Association between the Categories of Symptoms 
The occurrence of three kinds of symptoms discussed above correlated to each 
other. In our study, there were strong associations between the classification of climacteric i 
symptoms. Climacteric symptoms were consistently related to the estrogen deficiency. : 
:�‘ 
This is probably why their occurrences were positively correlated to each other. One , 
previous study found that depression was positively correlated to the severity of the 
vasomotor symptoms (74). Another study showed that mid-life women of reporting 
insomnia likely had higher psychological distress and somatic symptoms, especially 
musculoskeletal discomfort and fatigue, coinciding with their perceived insomnia (75). 
5. Climacteric Symptoms and Menopause 
The occurrence of climacteric symptoms may be affected by menopausal status. 
The results from a survey in Chinese factory workers showed that the climacteric 
symptoms were more pronounced at the perimenopausal period (68). In our study, 




likely to experience any climacteric symptoms than premenopausal women. It is 
consistent with the evidence of that the occurrence of climacteric symptoms may be 
affected by menopausal status (51-53, 76). 
6. Climacteric Symptoms and Socio-culture 
The difference in the occurrence of climacteric symptoms may be affected by 
socio-cultural. There are different attitudes and reactions to the menopause in different 
cultures. Thus, women from China and Japan in particular reported fewer perimenopausal 
complaints than women in the United State and Canada. The investigator attributed this to 
the contrast in the status of menopausal women in the two cultures, the Asian women 
escaping from the stigma of menstruation and gaining higher social status, the American , 
v^ 
women as well as Canadian women anticipating loss of status in a “youth-oriented” （，) 
,.i' 
society (1). 
Part Three: Disturbance in Sexuality 
1 • Mechanism ofDisturbance in Sexuality 
'.:1 
I.:, 
Many physiological changes occur in genital tract with estrogen deficiency during 
l'l 
menopausal transition (10). Several studies found that sexual disturbance can be 
influenced by ovarian hormone levels (88-90). Menopause brings remarkable changes in 
both appearance and function, which future result in thinning of mucosal surfaces, 
decreasing in size of estrogen responsive organs and increasing in vaginal dryness even 
pain (2). 
2. Sexual Activity and Menopause 
2.1. Decline in Sexual Activity 
The frequency of sexual activities is decreased during menopause. 66.4% women 
had sexual activities at least once a month in our study. One study also showed that only 
69% of climacteric females were sexually active (84). The decrease in the frequency of 
82 
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sexual activity was found even greater among postmenopausal women (81). One study 
showed that 48% of postmenopausal women experienced a decrease in sexual activity 
(86). Future, forty-two percent of postmenopausal women than fourteen percent of 
premenopausal women had stopped having intercourse aged between 45 and 55 years 
(222). 
2.2. Loss of Sexual Desire 
The major reason for having no sexual activity was a lack of interest. The 
frequency of reporting loss of interest differs from 13% to 79% in postmenopausal women 
(81, 86, 222). It was reported a marketable decline in the sexual interest of women aged 
between 45 and 55 years. In particular, among premenopausal women, seven percent had , 
.<f 
"no interest" in sex while thirty-one percent postmenopausal women did so (222). Other 
study showed the corresponding figure was 47% in postmenopausal women and 13% 
premenopausal women (86). 
3. Sexual Activity and Contraceptive Method 
The frequency of sexual activity was influenced by the satisfaction about 
contraceptive methods. Our study demonstrated that pre- and perimenopausal women who 
were satisfied with their contraceptive methods were 5 times as likely as those who were 
not satisfied to have sex at least once a month. Satisfaction on the methods for fertility-
. : 1 
regularity mainly depends on the efficacy and the frequency of side-effects, both on 
i ‘ 
/,： 
general health and sexuality. The fears of being pregnant for those using ineffective ‘ 
./^ 
methods and of harmful effects on health directly reduce the frequency of intercourse. 
Some methods may cause vaginal dryness, even pain. Such experiences of vaginal dryness 
and pain also interfere with the occurrence of enjoyment and orgasm during sexual activity 
(223). These would eventually lead to decline in the frequency of sexual activity. 
4. Decline in Sexual Function 
The sexual 
function tends to decrease in middle-aged women. Enjoyment and orgasm as measures of 
sexual function in our study were both related to menopausal status, occurrences of 
disturbance in sex, and the socio-economic class. 
83 
In our study, 61.7% of women enjoyed sexual activity at least half of intercourse 
among all sexually active women. The proportion of women experiencing orgasms was 
54.1%. In another community sample of middle-aged women, 72.1% of women found 
sexual activity at least half the occasions enjoyable (80). 
5. Sexual Function and Menopause 
The frequencies of enjoyment and orgasms are related to menopausal status. Peri-
and postmenopausal women were more than 50% less likely to enjoy sexual activity and 
to experience orgasm than premenopausal women in our study. 
Sexual function is largely considered oestrogen dependent. Oestrogen deficiency 
is an endocrine sign that starts several years preceding the final menstrual period and , 
progressively declines after the cessation of menstruation. : 
Several previous studies have consistently shown that the menopause leads to a 
decline in sexual response. In a study of Swiss women, the investigators found that 
menopause led to a decrease in the quality of the sexual experience (86). A few women in 
the postmenopausal group than none in the premenopausal group reported never enjoying 
sexual activity (80). It was also shown that the postmenopausal women found intercourse 
less satisfying and experienced a decline in orgasmic frequency (81). 
6. Sexual Complaints and Menopause 
:i 
The frequency of experiencing vaginal dryness and pain was significantly v 
I >•• 
increased during the menopause. Someone believed that vaginal dryness significantly “ 
related to menopausal development (51). It was reported that vaginal dryness and 
tenderness were experienced by 30% of the postmenopausal women and the discomfort 
tended to become more common as the time increases after menopause (74). 
7. Association between Sexual Function and Complaints 
The occurrence of vaginal dryness and pain experience influenced the sexual 
function. This study found that women who experience frequent vaginal dryness and/or 
pain during sexual activity were less likely to enjoy sexual activity and to experience 




In review of the changes of physiology in vagina during menopausal transition, the 
condition of severe atrophy or atrophic vagintis due to oestrogen deficiency results in poor 
vaginal lubrication and discomfort even pain during intercourse (2). Painful intercourse 
detracts from a person's sexual enjoyment and can interfere with orgasms (223). 
8. Sexuality and Socio-economic Class 
8.1. Frequency of Sexual Activity and Socio-economic Class 
The frequency of sexual activities is negatively related to the socio-economic class. 
Lower proportion of sexually active women was found from those with more number of 
pregnancies, parities and babies breast-fed, which indicate of lower socioeconomic class in 
our study. There was also a direct positive association between the frequency of sexually — 
.•»/ 
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active women and socio-economic class. For example, a significantly lower proportion of 
sexually active women was found in the groups who were with lower degree of education, 
who were in the lowest category of occupation, and who had a decreased income. Our 
findings confirmed that menopause is associated with a greater decline in sexual activities 
among women of lower social class (86). 
8.2. Sexual Function and Socio-economic Class 
Women of higher socio-economic class had a lower risk of decreased sexual 
functioning. Our study found that higher socio-economic class was related to a greater 
proportion of enjoyable sexual activity and orgasms. That is women who had more years 
',' 
M' 
of education and had taken any dietary calcium were more likely to experience sexual ,, 
enjoyment and orgasms. This finding was in agreement with the results from several 
previous studies. Positive associations were found between socio-economic status and 
frequency of orgasms and enjoyment of sexual activity in a community sample of middle-
aged women (80). Eleven to twelve years of education was association with a lowered risk 
of decreased sexual functioning (P<0.01) among women aged between 45 and 55 years 
(78). The decrease in the quality of the sexual experience was greater in women of lower 
social class was also found (86). 
8.3. Frequency of Sexual Complaints and Socio-economic Class 
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Sexual complaints were related to socio-economic class: the occurrence of vaginal 
dryness and painful experience was associated with women's socio-economic status in this 
study. The reasons for this are not clear. Our explanation is that women with higher social 
classes tend to emphasis more on youthfulness and the menopause is viewed as a negative 
event. Such personal attitudes may well affect the range of complains in sexuality. 
Further, women of higher social class differed in several sexual variables from 
those in lower social class, including recognition of libido, frequency of orgasms and of 
sexual problems. The above findings may also be a result of different levels of sexual 




Part Four: Illness Results from Menopausal Transition 
1. Fracture 
1.1. Prevalence of Fractures 
1^ 
The prevalence of fractures was 0.9% and it was much lower than that found in 
V >' 
other study populations. For example, it was 7.99% in cross-sectional survey among 
women aged 40-65 years in Beijing (23). The prevalence of vertebral fractures in the 1012 
women (mean age 64.4 years) was 7.8% (109). The reasons for the difference are possibly 
as follows: First, the sample of our study was healthy females at ages of 45-55 years 
drawn in a community. Second, women who were hospitalised were excluded from this 
study, therefore some women with current fracture would have been excluded from the 
study. 
1.2. Fractures and Menopause 
The occurrence of fractures is associated with menopause. The degree of bone loss 
was identical in late peri- and early postmenopausal women. Both the age at menopause 
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and the number of reproductive years had significant positive association with bone 
density at every site (104, 105). Some studies also suggested that early menopause was 
associated with a quantitatively greater bone loss than in women with menopause of later 
onset and thus it was considered as a risk factor for osteoporosis (107, 110-112, 114, 115). 
i 
； One study showed that both patient groups of spinal fragility fractures and recent hip 
fractures had bone density reduction at the spine and peripheral measuring sites as 
compared with healthy control subjects (98). It was also found that longer duration of 
menstruation was associated with lower fracture incidence (116). Women with premature 
menopause were at a greater risk for bone loss and had a significantly greater frequency of 
; hip fractures when compared with normally menstruating women (106, 113). The number 
of fractures in our data was too small to explore this association. ‘ 
^ 丨” 
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1.3. Fractures and Reproductive History : 
The length of menstrual period in days was inversely associated with the 
prevalence of the fracture in this study. It was confirmed by that long menstrual cycle 
length was related to reduced hip fracture risk in women (117). In the light of bone 
biology and ovarian hormones, this association may be expected. Progesterone promotes 
bone formation (224). It is likely that progesterone acts through stimulation of osteoblast 
function (94, 225, 226). It has also been shown that oestrogen increases osteoblast 
progesterone binding (94). Oestrogen acts to decrease bone resorption (227). For those 丨 
women who are with fewer days of menstrual period, their bone may expose to the chronic H 
relative absence of adequate progesterone levels, even exposes to normal oestrogen levels, 
will undergo little remodelling, and both resorption and formation are in the low-normal 
range (227, 228). 
The associations between the prevalence of fractures and parity, breastfeeding and 
oral contraceptive use have not been consistent. One study found that parity, lactation and 
use of the contraceptive pill were not significant predictors on bone density of 
premenopausal women aged 39-56 years (229). A prospective population-based study 
showed that parity and lactation did not differ between the fracture and non-fracture 
groups (230). It was reported that women with four or more parities had a risk of fractures 
similar to nulliparous women and women who breastfed for more than two years had a 
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risk of similar to women who had never breastfed (119). No significant effect of pill use 
on forearm fracture risk was observed in a cohort study of 46,000 women with 482,083 
person-years of follow-up. In contract, the risk of subsequent fractures among the women 
who had ever used the oral contraceptive pill was significantly greater than that among 
women who had never used it. These data do not support the hypothesis that pill use 
protects women against the occurrence of osteoporotic fractures in later life (231). 
However, some studies demonstrated that high parities not only have protective 
effects on bone mineral density (BMD) but also are associated with a reduced incidence of 
fracture (116, 117, 231). Each birth was associated on average with a 9% reduction in the 
odds of hip fracture, although the trend was not statistically significant (232). Breast , 
feeding may protect parous women against hip fracture in old age (118). It was found in J 
two previous studies that a history of oral contraceptive use was protective against low 
I bone mineral density and that the degree of protection from lower BMD was related to 
j duration of exposure (120, 121). The prevalence of fractures in our study was so low that 
} the association can not be examined. 
I 
1.4. Fractures and Socio-economic Factors 
So far there is still uncertainty of the associations between the prevalence of 
fracture and genetic, life style factors, and social class. Calcium intake, level of exercise, 
obesity, smoking and alcohol intake were not significant predictors on bone density. Thus , 
I '；' 
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the author suggested that lifestyle may not be the major determinant ofbone density before , 
the menopause (229). Another study found that the fracture prevalence was not correlated 
with socio-economic groups (233). However, genetic and lifestyle factors affected peak 
bone density and were related to the differences in hip fracture were shown in one study 
(123). It was also discovered that women with higher socio-economic level had greater 
spine bone mineral density than those women with lower socio-economic class (124). One 
study however showed that fracture risk was lower among those of lower socio-economic 
class (231). Risk ofhip fracture was found to be associated with the level of exercise (234-
236). Our data can not provide any useful information on this since there was too small 




It was also found that body mass index positively was related to the event of 
fracture in our data. This is consistent with the theory that petite women (<1.5m) with 
small bones are at the higher risk of osteoporosis (122). The equation for calculating the 
2 
body mass index (BMI) is weight/height , where weight is in kilogram and height is in 
meter. Keeping weight the same, a decrease in height equally results in an increase in 
BMI. On the other hand, an increase in BMI can be a result of a decrease in height. 
2. Heart Disease 
2.1. Menopause and Heart Disease 
Our Study found that the prevalence of heart disease was increased following 
menopausal transition. This is in agreement with the result from one study: incidence rates " 
•I :i 
in perimenopausal and postmenopausal intervals were twice more than those in 
premenopausal intervals (133). These findings are consistent with other available 
evidences: First, menopause adversely affects the lipid and lipoprotein metabolism and 
may thus increase the risk of coronary heart disease (CHD) (129, 130); Second, 
menopause is associated with enhanced stress-induced cardiovascular responses and 
elevated ambulatory blood pressure during the workday (128). Third, a postmenopausal 
rise in fibrinogen level and early menopause are associated with higher fibrinogen level 
that may be related to an increased risk of coronary heart disease (125-127). Finally, there 
is an increase in insulin that is a risk factor of coronary heart disease in menopausal 丨 
‘； 
women (132, 138). v.； 
2.2. Oral Contraceptive Use and Heart Disease 
There was an argument about the association between the prevalence of heart 
disease and a history of oral contraceptive use. One study showed that the use of oral 
contraceptives was associated with lower levels of lipoprotein compared to non-users 
(136). It was consistently found that women with a history of oral contraceptive use had 
significantly lower fibrinogen level (126, 127). Lipoprotein, fibrinogen were the risk 
factors of coronary heart disease (125-127, 132). One study found that taking oral 
contraceptive tablets did not influence the frequency of CHD (237). Lack of association 
between the prevalence of heart disease and the history of oral contraceptive use was 
found in our study. In contract, it was found that 0 . C. users showed an increasing some 
lipoprotein level (137). It was also found that use of oral contraceptives appears to induce 
89 
an increase of insulin-resistance markers (138), which have recently been cited as risk 
factor for ischemic vascular disease (138, 139). Clinically, O.C. use increased the risk of 
myocardial infarction by 1.8-fold compared with non-use (140). 
2.3. Heart Disease and Age 
•'i 
After adjustment for menopausal status, body mass index and other factors, it was 
1 
:| shown that age remained to be positively related to the prevalence of heart disease in our 
-j 
'i 
丨 study. This finding was evidenced by one study in Japanese: the prevalence of 
: cardiovascular disorders increased with age (238). Age-induced changes in cardiac 
structure, function, and neuro-hormonal responses may modify cardiovascular function 
(239). 
一 
3. Arthritis ；  
3.1. Prevalence of Arthritis 
The prevalence of arthritis was 12.4% in this study sample. However, the 
prevalence of definite rheumatoid arthritis (according to ARA criteria in 1958) was 0.3 
per cent in urban subjects in Indonesia (240). The same prevalence was 0.9 per thousand 
in Pakistan (241). The discrepancy between studies may be due to the criteria of definition 
used. In our survey, the prevalence of arthritis included all diagnosed arthritis by doctors. 
3.2. Menopause and Arthritis 丨 
；‘’ 
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Postmenopausal women were 88% more likely to suffer from arthritis than 
premenopausal women in our study. This is compatible with that the average woman 
develops the first symptom at the time ofher menopause (141). 
3.3. Income and Arthritis 
Women with higher monthly income had a reduced risk of arthritis. This may be 
the effects of economic status on both the occurrence and the treatment of arthritis, 
including rheumatoid arthritis and non-rheumatoid arthritis. The long term care for 
rheumatoid arthritis is expensive. Classic and definite rheumatoid arthritis affects from 0.5 
to 1 percent of the United States' population aged 20 and 80 years. In 1983, the direct cost 
(out-of pocket expense for medical care) was $777 million, and the indirect cost (loss of 
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productivity) was $215 million, with a total of approximately $1 billion (242). There are 
associations between educational level, occupation and income status. The negative 
associations were found between education level, occupation and income and prevalence 
and severity of arthritis (155). Lower level of education is found to be related to more 
severe disease at onset. It was also found that patients with lower levels of education tend 
to have worse outcome (156). Subjects who had more than a high school education were 
found to have received much more comprehensive care than any other subgroup (157). 
Patients with RA and having higher levels of formal education are more likely to be 
hospitalised or to undergo surgery for RA (158). In one study, at least 28% of patients had 
lower annual income than the year before disease onset (159). The disease characteristics 
were followed in importance by socio-economic factors (160). Several studies also found “ 
-i ‘‘ 
» I 
that many potential predictors of occurrence of arthritis were related to patients' 





i Part Five: Contraception of Perimenopausal Women 
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In this survey, contraceptive status was recorded only in pre- and perimenopausal 
women. 64.9% of them were using some forms of contraception. This is similar to one 
previous study among women of similar age range. In the study, of 714 menstruating 
women aged 40-57 years, 62% were utilising contraception of various kinds (169). One 
survey among younger women aged 15-45 years reported that 73% of sexually active 
women were using reliable methods of contraception (246). 16.2% of sexual active pre-
and perimenopausal women were not using any contraceptive method in our sample. It 
was close to 18% found in a study of sexually active women at ages of 15 to 44 years 
(247). Higher frequency of contraception was found among younger age group of women. 
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In particular, 88% of Swedish women ages 23-29 years were using some contraceptive 
methods (176). 
2. Frequency ofEach Method Used 
The frequency of methods used differs from the culture to culture. In our sample, 
the common contraceptive methods used were intrauterine devices (IUDs) and barrier 
methods. The less common methods used included sterilisation and natural method. The 
least used method was oral contraceptive. In a sample of 1746 women aged 40-57 years it 
was reported that barrier or natural methods were mostly used ones among contraceptive 
methods. 9% of women aged 40-44 used combined oral contraceptives (169). A survey 
.if 
carried out in women aged from 15-49 years showed that 29.2% had been sterilised and ； 
34.4% were on the pill (175). 27% of married women are sterilised and it was estimated 
that 30 million men had undergone voluntary sterilisation in China (193, 195). 
\ The age plays a key role in the contraceptive choice. The mostly used methods in 
j young women were the oral contraceptive or condom (248). Italian women showed a very 
j high prevalence of oral contraception use, while use of IUDs was declining. Other 
丨 methods, such as barrier and natural methods, had been less frequently used (249). The 
most common method among Swedish women aged 23-29 years was hormonal 
contraception (43%), followed by a barrier method (22%) (176). In a community-based 丨 
’. || 
study among Swedish women aged 15-34 years reported that pills were presently used by 
.fi' 
42% of women using any contraceptive means, followed by condom (23%), IUD (19%) 
and other hormonal methods (10%) (177). More than 50% ofNorwegian women aged 20 
I to 44 years used either oral contraceptives (21%) or IUDs (30%). In the age group of 40-
I 44 one out of three women was sterilised (178). The percentage of using of oral 
1 contraceptives was decreased with age from 60% in women 20-24 years old to 1.5% in 
I women of 40-44 years old. The use of IUDs increased from 6% in the youngest age 
..1 
group (20-24 years) to more than 30% among women aged 40 to 44 years (178). 
;j 
I 
3. Efficacy of Contraceptive Methods 
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The efficacy for IUDs and condoms were 98.4% and 96.3% respectively. The 
efficacy of other methods, such as oral contraceptive use, natural method and sterilisation, 
all were 100% during the previous 12 months in this survey. Such high efficacy of 
methods among women aged 45 to 55 years is probably partly due to a decline in both 
sexual activity and fertility in mid-life. 
3.1. Decline in Sexual Activity 
The sexual activity decreased in middle-aged women. A decline in sexual activity 
was found with advancing years, especially after 40. For example, The average frequency 
of intercourse in four weeks was 6.5 times among women aged 43-44 years while it was 
12.1 times among women at aged 19-20 years. The frequency of sexual activity at age of , 
3 • 
44 was halved compared with women with aged 19-20 years (166). 
.i 
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j In both men and women sexual behaviour in middle age is greatly influenced by 
j 
socio-cultural background. In some parts of Asia there is evidence that coitus in couples 
I aged between 40 and 50 is significantly lower than among those in the West (69). Two-
I ] 
thirds of women are abstaining sexually by the age of 40 and nine-tenths by the age of 46 
was found among the Yoruba in Nigeria. Apart from socio-cultural reasons for lower 
sexual activity in middle aged people, it has been shown that there is often a decline in 
sexual interest at older ages in women (86). In our study, only 33.5% of premenopausal 
and 21.3% of perimenopausal women had sex at frequency of more than twice per month. 
f 
3.2. Decline in Fertility of Women at Mid-life 
The fertility declined progressively. Two hundred years ago, in parts of Europe 
where there was no voluntary control of fertility, 30% ofall births occurred in women over 
35 years of age. Even a decade ago one in 10 births occurred in women of this age group, 
but today it is less than one in 20. Even in traditional societies the mean age for having 
the last child is 40, although the menopause may not come for another 10-year (69). When 
the birth rates of large samples of women in historically non-contraceptive-using 
populations were examined, the results depicted a sharp decrease in births, starting at age 
of 40 (250). According to the US Bureau of Census statistics for 1976, live birth rate per 
1,000 mothers showed a tremendous decline for the period of highest fecundity: 112.1 for 
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age 20-24 that is in sharp contrast to 4.3 for the ages of 40-44 years (164). A similar trend 
can still be seen in the US Census statistic: in 1985 there were four live births per 1,000 
women aged 40 to 44, and 0.2 live births per 1,000 women aged 45-49 (164). A consistent 
feature of all societies is the marked decrease in fertility 7-10 years before the menopause. 
Modem endocrine assays have shown a coincident change in follicle stimulating hormone 
(FSH) and oestradiol levels at this age, 10 years before the menopause (165). 
3.3. Effective Methods Used 
Oral Contraceptives One multicenter trial of oral contraceptives in Thai women 
showed that no pregnancies occurred during 6 cycles of 783 women (179). 
IUDs A multicenter prospective 7- year randomised study showed that annual 
pregnancy rate for IUDs was 0.2 per 100 women (186). It varied from 0.0 to 1.7 per 100 
women for Tcu 380A IUD (187), 1.2% for Nova T and 0.1% for LNG-IUD (188). 
Barrier Method Pregnancy rate after 24 months of use was 2.5 for the diaphragm 
and 3.2 for the condom group per 100 women-year (251). However, while vaginal 
spermicides in combination with barrier methods or an IUD, there were no unplanned 
I pregnancies (252). 
Natural Method It was also no method failure for the natural family planning from 
I a study (253). The annual pregnancy rate of 2.6 per 100 women-year in the rhythm group 
^ 
.1 
was found in another study (251). 
.1 y 
； Sterilisation Sterilisation was very efficacious. No pregnancy occurred in women 
！ sterilised with minilaparotomy tubal sterilisation (196). The failure rate for the first five 
1 years of sterilised women by the laparoscopic and minilaparotomy procedures was one per 
cent (197). Four-year follow-up of the patients found only one case of pregnancy in the 
culdoscopy group (198). 
4. Advantages and Disadvantages of Contraceptive Methods 
！ 
4.1. Oral Contraceptives 
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In oral contraceptive group in this survey, no complaint was found. More than 
90% felt satisfied either due to its high efficacy or its lack of side-effects. Our results are 
consistent with that oral contraceptive use truly provides reliable contraception with good 
general tolerance and excellent cycle control and very low rate of side effects (180-183). 
4.2. Intrauterine Devices 
The major benefit of IUDs was its high efficacy. The minor ones were harmless to 
health and easy to use. 12% of IUD users reported some side-effects, such as heavy 
bleeding, spotting and backaches. Previous studies showed that a comparison of IUD 
users by age at IUD insertion and age at IUD removal or last visit to the clinic showed that 
women aged over 40 tolerated IUDs better than younger women (185). Both women and 
physicians considered that IUDs are easy to use, effective, safe and have few side effects. 
A study found that major disadvantages reported by women were bleeding, pain, infection 
I and pregnancy (254). Another previous study discovered that the major problem of IUDs 
k 
was the increased incidence ofbleeding or dysmenorrhea (172). 
4.3. Barrier Method 
Among barrier method group, 12.5% of barrier users in our sample experienced 
some discomfort during sexual activity. One previous study also found that the only side 
effect of condom usage was reduced sexual excitement (192). There are changes in the 
1 
,j 
丨 physiology of vagina due to oestrogen deficiency 7-10 years preceding the menopause. 
The experiences of vaginal dryness and pain may occur because of the atrophic vaginitis ‘ 
• i 
and other changes (2). Barrier, of which the most frequently used is condom, is -
.| intercourse-related method. It may cause or intensify the dryness or pain during sexual 
•) 
:l activity. 
丨 4.4. Natural Method 
.:! 
丨 In the natural contraception group, 29.3% of users considered it an effective 
;i 
method in our survey. One pilot-study in women aged 18-49 in the Westem Europe 
reported that natural methods showed a use-effectiveness that can be compared to that of 






One principal benefit of sterilisation was the lack of side-effects in this study. The 
previous studies showed that there was no statistically significant difference in the 
percentage of ovulatory cycles within the sterilised women and the control groups (201). 
They also indicated that normal hormonal profiles were retained after tubal sterilisation 
(202). They reported that no significant changes in menstrual blood loss (MBL) were 
observed after the four sterilisation techniques (204). 
5. Satisfaction Rates of Contraceptive Methods 
5.1. Satisfaction Rates 
The satisfaction rates among this age group were higher than that of other age 
groups. In particular, The percentages of satisfaction with contraceptive methods from our 
data among O.C. use, IUD insertion, and sterilisation were 100%, 91.2%, and 95.2% 
respectively. One oral contraceptive was found acceptable by more than 90% of the 
women of reproductive age (minimum age was 18 years and mean age was 25.6 years) 
involved in a trial (255). More than 97% of Chinese subjects reported satisfaction with the 
methods (IUDs or Norplant) used by themselves (256). 94% of women satisfied with their 
decision ofbeing sterilised (257). Over 98% women indicated that they were satisfied with 
their sterilisation procedure (258). The data of satisfaction rate on barrier method and 
natural method were not available to compare with our results. 
5.2. Satisfaction Rates between Menopausal Status 
) 
In our study, it was found that satisfaction rate was only related to the menopausal , 
status, in particular, premenopausal and perimenopausal group explained different 
satisfaction rate (p=0.0175). It may be the complex reflection of many factors on the 
satisfaction of methods used. Perimenopausal women complained not only more 
vasomotor and psychological symptoms, but also more vaginal dryness and pain 
experiences during intercourse, all of those inversely associated with satisfaction on the 
methods for fertility-regularity. 
6. Choice of Contraception 
6.1. Choice of Oral Contraceptives 
Factors influencing the choice of contraception method was examined in our study. 
vj 
丨 The number of O.C. users is too small to explore any association in our sample. 






The number of parities is related to the choice of using IUDs. In the IUD users, the 
number of parities was found to be associated with the choice of IUD insertion. Women 
with one child were more likely choose insertion ofIUD, one of reversible methods. While 
women already have two or more children, they were more likely choose sterilisation, 
which is not reversible. One previous survey by the State Family Planning Committee of 
China among 2880 women in east China showed that the predominant choice after first 
delivery was the IUDs (259). 
The choice of using IUDs is related to the frequency of sexual activities. In IUD 
group of this sample, there was also a positive association between the frequency of 
monthly intercourse and the proportion of using IUD. IUD is not intercourse-related 
method so that IUD does not interfere with enjoyment and orgasms during sexual 
activities. Therefore, IUD users had more sexual activity; in return, women with more 
active sexual activity were more likely to choose insertion ofIUD. 
6.3. Choice ofBarrier Method 
Again, the number of parities was a predictor for choosing to use barrier method. 
In the barrier group in this study, there was a negative association between the number of 
parities and the frequency of using barrier method. 
The choice of using barrier method is also related to the frequency of sexual 
activities. However, the direction was the other way around. In particular, sexually more 
1 active women were less likely to choose barrier method as contraceptive method. In retum, s 
women depending on barrier method to protect from pregnancy had a reduced frequency 
of intercourse. This may indicate that the condom is intercourse-related and may cause 
vaginal dryness even pain, especially among middle aged women with declined oestrogen 
levels. In addition, it was found that condom use was associated with reduced sexual 
excitement (192). 
6.4. Choice ofNatural Method 
The choice of natural method is related to women's income. In the natural group of 
our sample, women with higher income were more likely to use periodic abstinence for 
； birth control. With a decline in both fertility and sexual activity in this age group as 
discussed above, an accurate use of natural contraception may provide sufficient 
protection from pregnancy. Women with higher income were more educated and of upper 
social status. The efficacy may be higher in this group of women. The success in 
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protecting from pregnancy might increase the confidence of use and therefore increase the 
possibility to use natural method. 
( 








The mean age at natural menopause was 48.2 years in Chinese women in urban 
area of Beijing City, China. It was consistent with those found from other studies in the 
Asian countries. It was influenced by reproductive and socio-economic factors. 
Vasomotor symptom increased in both peri- and postmenopausal periods. 
Psychological symptom increased in the perimenopause, however, it tended to decrease 
after menopause. Bone-joint problems were inversely associated with daily activity and 
physical exercise. The occurrences of these three kinds of symptoms were positively 
correlated to each other. 
The sexual activity and the sexual function were declined and the disturbance in 
sexuality was increased during perimenopausal period. There was an interaction between 
the declined sexual function and increased disturbances in sexuality. The sexual function 
was associated with the socio-economic status. 
Age was the predictor of the occurrence of heart disease. The prevalence of 
arthritis was related to menopause. Women with increasing income had a lower prevalence 
i 
of arthritis. 
The primary method used by perimenopausal women for contraception was IUD 
and barrier method. The choice of using IUD and barrier method was related to the 
number of parities and the frequency of sexual activities. However, the frequency of using 
natural method was associated with the income status. 
99 
Implications and Recommendations 
Our finding of that women breastfed and were of higher socio-economic class had 
a delayed age at natural menopause implies that the time of the onset of menopause may 
be influenced by the environmental factors. We recommend women for breastfeeding 
babies and improving themselves socio-economic status to delay the cessation of 
menstruation that is protective from osteoporosis and heart disease. 
The finding of the occurrences of vasomotor, psychological, and bone-joint 
symptoms being strongly correlated to each other provides an evidence that any therapy 
for perimenopausal symptoms can alleviate all three kinds ofcomplaints. 
Since there were high prevalence of heart disease and arthritis and frequent 
reporting of climacteric symptoms among perimenopausal women, we recommend the 
scientists for researching hormone replacement therapy or Chinese herbs to improve the 
health status and to alleviate the perimenopausal symptoms. 
A special clinic for perimenopausal women is suggested to be set up in certain 
health centres and hospitals. It provides an opportunity for perimenopausal women to 
know what menopause means; which symptoms and diseases accompanied this transition; 
what the women should care for and what hormone replacement therapy is. Besides, 
women complaining severe symptoms or suffering from osteoporosis can receive an 
appropriate treatment here. 
Bone-joint problem was associated with daily activity and physical exercise 
implies that the sufficient way to reduce the bone-joint problems that are the most 
common complaints during perimenopausal period is to encourage women, especially 
sedentary women to increase daily activity or participate any physical exercise. 
Our finding of the prevalence of arthritis being negatively related to the income 
status implies that improvement of women's economic status will sufficiently decrease the 
prevalence of arthritis that is the most frequent disease among middle-aged women. 
Of the findings that the frequency of sexual activities was influenced by 
satisfaction on contraceptive methods suggested that to enhance the well-being of middle-
aged women, it is important for scientists and government officers of family planning to 
provide perimenopausal women some appropriate methods for birth control. 
丨 1 0 0 
Our finding was that women in urban area with one parity were more likely to 
choose IUD or barrier method for contraception. The fact is that women in the cities in 
China almost all have only one parity. Therefore, our study suggested that studies on the 
efficacy, side-effects and acceptability of IUD and barrier method used among middle-
aged women are necessary and urgent to perform. 
There was a high frequency of reports of bone-joint complaints and also a high 
prevalence of arthritis among the study population. However, the frequency of hormone 









The limitation of this study includes the design of questionnaire, the sample size, 
age range of sample, the accuracy of the self-reporting age and recall bias. 
In the design of question, some potential factors, which are influenced by the 
improvement of national economy and may affect women's health status, such as dietary 
habit, daily activity, degree of labour, leisure time and environment, frequency of medical 
care, medical insurance, should have been added to the examination items. The 
consideration was that these factors are complex for them to answer. The questionnaire 
was designed as simple as possible due to the limited period of data collection. Another 
one was that some items are much new concept for Chinese women. 
The final sample size was 788 respondents and 742 of pre-, peri-, and naturally 
postmenopausal women were included in the data analysis. The estimate of age at natural 
menopause was done among 260 naturally postmenopausal women. The assay of sexual 
function was limited among 486 women who were sexually active in the past three 
months. Contraceptive status was examined with a subgroup of 313 women who were 
either pre- or perimenopausal and were current contraceptive users in the previous twelve 
months. 
The limitation for the sample size was objectively due to the duration of data 
collection. In a period of six months, it was scheduled to design the questionnaire, pre-test 
and modify it, copy and pack it; to carry out sampling, pilot study, and main study by face 
to face interview at clients' home and to perform quality control and check the 
questionnaires; to enter data twice and doubly check the entered data. All of work had to 
be done by one investigator in this limited duration. 
The age range of sampled women was between 45 to 55 years. This limited the 
estimates of age at natural menopause. In a sample of 1413 women aged 40-66 years, 714 
(50.5%) of women were still menstruating. The oldest menstruating women were 57 years 
old (168). Another survey was carried out among perimenopausal women aged 40-65 year 
in Beijing. The age range of natural menopause was 22-61 years (23). In our sample two-
third of respondents were still menstruating. Thus, the age at natural menopause was 
underestimated in this age group of sample. However, another focus of this study was on 
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the frequency of climacteric symptoms during perimenopausal period, including 
premenopausal, perimenopausal and early postmenopausal women. If the age range was 
wider, more premenopausal women with younger ages and more postmenopausal women 
of older ages would be recruited into the sample, both have less frequently reporting of 
climacteric symptoms. 
The bias in the self-reported ages was not been avoided successfully. Some dates 
ofwomen's birth were based on the Chinese calendar. The difference between the Chinese 
calendar and the calendar was one to two months. Therefore, the age at natural menopause 
for those women whose dates of birth were based on the Chinese calendar may be 
overestimated in months. 
There was a high proportion of the study sample having college level of education 
and above. This can possibly be explained by the follows. First, women who had got any 
education more than high school (12 years), whether they studied by full-time or part-time; 
whether they were educated at colleges or evening schools; whether they were taught in 
person or by televisions and correspondence; whether they got the Bachelor degree or not; 
were all included in the education level of college. Second, there was a possibility of that 
women with higher level of education were more aware of the term of "menopause", 
therefore, they were more active to participate this interview in order to know more about 
it. It was the same explanation for that there was a high proportion of women being white 
collar workers. 
Recall bias was still involved in this survey although we tried the best to avoid it. It 
was the same as other retrospective study. First of all, recall bias on the time of final 
menstrual period. The final menstrual period for some of naturally postmenopausal 
women was several years ago. In our questionnaire, only year and month were required. 
Those women were asked to remind of some milestone, both from her family and society. 
If they cannot remember the month, code '06'(the mid-year). The second recall bias was 
the menstrual and reproductive history. These events for them happened twenty or even 
thirty years ago. The items about the menstrual and reproductive history were designed to 
be as simple as possible. The third one was the recall bias in recall of symptoms, sexual 
function and disturbances, and contraception. To avoid these recall bias, women were 
asked to recall the symptoms which occurred in the precious 2 weeks; about sexual 
function and disturbances questioned only among those sexually active women and within 
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the previous three months; the experience of contraception was limited in the past twelve 
months among those current users. The estimation of the prevalence of disease was based 
on women's self-reporting. However, the resources do not permit us to examine each 
woman who reported any disease that was diagnosed by the doctors. Therefore, the 
accuracy of the prevalence of diseases was not absolutely certain. 
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Appendix: Translation of Questionnaire 
Name: (In Chinese) (In English) 
Age L J _ 
Date of Birth _ _ _ ~ L _ 
Date of interview L _ L _ L J _ 
51. Have you had any of the following operation or procedures? ^ 
0 = None 
1 = Removal of one ovary only 
2 = Removal ofboth ovaries 
3 = Removal of the uterus only(hysterectomy) 
4 = Removal of the uterus and one ovaries 
5 = Removal of the utems and both ovaries 
52. Have you had a menstrual period in the past twelve months? ~ " 
1 = NO (GO TO QUESTION S4) 2 = YES U 
S3a. Have you had a menstrual period in the past three months? ^ 
1 = N 0 2 = YES 
S3b. Compared to twelve months ago, would you say that your ~ 
periods are less regular, or has there been no change? 
1 = Less regular 2 = About the same regularity 
3 二 STOPPED 
S3c. Compared to twelve months ago, is your menstrual flow... ~ 
1 = Lighter 2 二- About the same ~~ 
3 = Heavier 4 = Variable 
5 = STOPPED 
54. When was your last menstrual period? ~ ~ ~ ~ ~ ~ ~ 
55. Menopausal status (For office use only) ~ 
1 = Surgical menopause 4 = Natural postmenopause ~~ 
2 二 Premenopause 5 二 Other(specified ) 
3 二 Perimenopause 
Reproductive History 
1 a. How old were you when your menarche? ~~~~ 
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lb. Was your menstrual cycle regular or not while your fertile years? ~ " 
1 = Irregular (GO TO QUESTION ld) U 
2 = Regular 
lc. How many days was your menstrual period ？ 
ld. Have you had any episodes of amenorrhea for equal or ~~ 
more than six months? 
l = N o 2 = Yes 
2a. How many times have you been pregnant? ^ 
2b. Times of live birth ~ 
Times of still birth ^ 
Times of spontaneous abortion ~~ 
Times of induced abortion ~~~ 
2c. When was your first full-term pregnancy? ~~~~~~~~ 
3a. Have you ever fed your babies? ^ 
1 = No (GO TO QUESTION 4) 2 = Yes U 
3b. How many babies have you fed? ^ 
3c. How many months have you breastfed your babies totally? ― ^ 
4. Have you ever taken oral contraceptives ~~ 
0 = No l = Y e s ~~ 
Perimenopausal Symptoms 
5. I will read you a list of common problems which affect us from 
time to time in our daily lives. Thinking back over the past two 
weeks, have you been bothered by any ofthe following? 
0=No l=Yes � 
a. Dizzy spells _ 
b. Lack of energy _ 
c. Diarrhoea _ 
d. Constipation _ 
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e. Persistent cough 
f. Feeling blue or depressed [ 
g. Backaches 
h. Upset stomach ~ 
i. Headaches ^ 
j. Cold sweats ~ 
k. Aches/stiffness injoints ^ 
1. Shortness ofbreath ~~~ ！ 
1 
', 
m. Hot flushes ~~ , 
n. Sore throat ~~~ 
0. Trouble sleeping ^ 
p. Loss of appetite ^ 
q. Fluid (water) retention ^ 
r. Difficulty in concentrating ^ 
s. Nervous tension ~~ 
t. Urinary tract/bladder infections ~~ 
u. Rapid heartbeat ~~ 
V. Tins and needless' in hands or feet ~~ 
6. Have you had any menstrual problems in the past twelve months? _ 
1 = No (GO TO QUESTION 7) 2 = Yes L_ 
3 二 Postmenopause(GO TO QUESTION 7) 
6a. What is the main menstrual problems? ~ 
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Sexuality 
7. What would be your average frequency of sexual intercourse over ^ _ ^ 
the past three months? L_L_ 
(00 二 no intercourse) (if no, ask question 7a) 
7a. What's the principal reasons or condition for no intercourse? ~~ 
8. Over the past three months on what proportion of occasions that ~~ 
you made love did you find it a pleasant experience? ~~ 
1 = All 2 = More than half 
3 = About the half 4 = Less than half 
5=Ni l l 
9. How often during the past three months have you experienced a ~ 
orgasm during the sex? 
1 - All 2 二 More than half 
3 = About the half 4 = Less than half 
5 - N i l l 
10. Over the past three months on what proportion of occasions that ~~ 
you experience vaginal dryness in sexual intercourse? 
1 二 All 2 = More than half 
3 = About the half 4 = Less than half 
5=Ni l l 
11. How often have you experienced pain during sexual activity in the ~~ 
past three months? 
1 = All 2 = More than half 
3 = About the half 4 = Less than half 
5=Ni l l 
Contraception 
12. Have you ever used any methods for birth control in the ~~ 
past twelve months? ~~ 
1 = No (GO TO QUESTION 17) 
2 = Yes 
3 = No intercourse (GO TO QUESTION 17) 
4 = Single (GO TO QUESTION 17) 
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13. What was the main method which you have used for family ~~ 
planning in the past twelve months? 
1 = Oral contraceptives 
2 = Intrauterine devices 
3 = Barriers 
4 = Natural methods 
5 = Male or female sterilisation 
14. Have you ever been pregnant during the past twelve months? ~ 
l = N o 2 = YES U 
15. How satisfied are you with the method you have used now? ~ 
1 = Very satisfied 2 = Just satisfied ~~ 
3 = Not satisfied 
16. What is the major advantage and disadvantage of the methods ^ 
which you have used for contraception during the past twelve ~~ 
months? 
Common Disease 
17. During the past twelve months, have you been told by the doctors 
for the first time that you have any of the following conditions or 
any conditions happened one year ago? 
0 = No 
l = Y e s 
2 二 One year ago, not recovered 
I a. Diabetes (high blood sugar) L_ 
b. High blood pressure _ 
c. Heart disease _ 
d. Fracture _ 
e. Arthritis or rheumatism __ 
f. Cholecystitis/cholelithiasis __ 
^ g. Vagintis — 
h. Urethritis/cystitis | _ 
I. Other conditions which is not included in the above list ~~ 
0 = No 1 = Yes (specified below) ~~ 
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Medication 
18. We also need to know about whether you use hormones or not ,1 
am going to read a list of common hormones. For each one, please 
tell me if you have been taking in the past twelve months? 
0 = No 1 = YES 
a. Hormone pills for menopause or ageing symptoms \ _ 
b. Hormone creams for vaginal dryness _ 
c. Hormone for regularising menses __ 
i 
d. Insulin : 
I 
e. Thyroid pills _ 
f. Other hormones [ 
g. Drugs other than hormones, if YES, specified below | 
Marital Status 
i 
19. Are you: ~~ 
1 二 Married living with your husband 
2 = Separated or divorced 
3 二 Widowed 
4 = Never married 
21. In the past twelve months, has anyone close to you: 
(0 = No 1 = YES) 
a. Been seriously ill _ 
b. Died [ 
c. Been particularly demanding of you _ 
d. Caused you any special worry _ 
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Socio-economic status 
22. What was your degree of education? ~ 
1 = None 4 = High School 
2 = Primary School 5 = College or University 
3 = Middle School 6 = Graduate School 
22a. How many years have you been educated? ~ " ~ 
(00 = None) ~~~~ 
23. Have you been employed during the past twelve months? ~~ 
0 = No (GO TO QUESTION 27) l = Y E S U 
2 = Never employed 
24. What is your present occupation ( )? ~ 
25. How long have you been working as a ~~~~ 
(STATE OCCUPATION)? (ROUND TO NEAREST YEAR) ' " ^ 
26. How would you describe your present job? ~ 
1 = Interesting most or nearly all of the time 
2 = Interesting some of the time 
3 二 Not interesting 
27. How would you describe your house work? ~ 
1 二 Interesting most or nearly all ofthe time 
2 = Interesting some of the time 
3 二 Not interesting 
i 
28. In the past twelve months, has your total household income.... ~~ 
1 = Stayed the same 
2 = Decreased 
3 = Increased 
4 = DO NOT KNOW IF IT HAS CHANGED 
29. How much does your household income(In RMB Yuan each ~ ~ ~ ~ ~ ~ ^ 
person per month) 
(If do not know, coded as 9999) 
30. Which kind ofhouses have you lived? ~ 
1 二— Singe-story house ~ 
2 —  Apartment 
31. What is the average area have you lived now? ~~"~ 
(In square meter per person) ~~~~ 
111 
Habits and Others 
32a. Have you ever smoked? ~ 
1 二 Never 2 = Smoked, but stopped 
3 二 Been smoking 
32b. How many years have you smoked? ~~~~ 
32c. On the average, how many cigarettes do you smoke per day? ~ ~ ~ 
33a. Have you ever dmnk any alcohol or wines? ^ 
1 二 Never 2 二 Drank, but stopped 
3 = Been drinking 
33b. How many years have you been drinking? ~~~~ 
33c. Average speaking, how often? """ 
1 = Once a week 
2 = More than one per week 
3 = Equal or more than one per day 
33d. Which kind of drinking have you usually drunk? [ 
1 = Beer 2 : Wine 
3 = Wine with Chinese medicine 4 = Alcohol 
34. In the past twelve months, have you regularly been supplied any 
kind of calcium? 
0 = No l = Y E S 
3 5. Over the past twelve months have you regularly taken part in any 
physical activity? 
0 = No l = Y E S 
36. Has your mother ever been fractured? ^ 
l = N o 2 - Y e s 
3 = DO NOT KNOW 
37. How tall you are7(In cm) ~~~~~~~ 
(What is your height?) 
3 8. How heavy you are7(In kg) ~~~~ 
(What is your weight?) 
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Your address, zip code and phone number 
Address: 
Zip code: 
Office telephone(if any) 
Home phone number(if any 
Call number(if any) 
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